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A structure common to all vertebrate species is their axial skeleton, which is composed of  
calcified extracellular matrix deposited by bone forming cells (osteoblasts). In this thesis, I used 
two laboratory fish models, medaka (Oryzias latipes) and zebrafish (Danio rerio), to gain better 
understanding of the cellular and molecular processes involved in skeletal development.  
To examine the role of osteoblasts in development of the vertebral column, I created a transgenic 
osx:CFP-NTR medaka line which enables conditional ablation of this cell lineage upon antibiotic 
treatment. Ablation of  a substantial number of osteoblasts, which was evident by reduced 
reporter expression, enhanced apoptosis in the respective regions and reduced marker gene 
expression, led to reduced bone mass in the cranial skeleton and the vertebral spines. In contrast, 
vertebral bodies were found partially fused as a consequence of osteoblast ablation. Thus, I 
propose an additional function for osteoblasts as growth restricting border cells in development of 
the segmentally organized vertebral bodies.  
In the course of vertebrate development, cranial neural crest cells (CNCCs) undergo epithelial to 
mesenchymal transition (EMT), delaminate from the neural plate border and migrate in distinct 
mesenchymal streams to invade the respective cranial regions where they eventually differentiate 
to form the craniofacial skeleton. Canonical Wnt signaling is one of the essential cascades 
implicated in this process. Here I show that the frizzled co-receptor low-density-lipoprotein 
(LDL) receptor-related protein 5 (Lrp5) plays a crucial role in CNCC development and 
morphogenesis of the cranial skeleton. While Morpholino mediated knock-down of lrp5 does not 
affect induction of CNCC, it leads to reduced proliferation of premigratory CNCCs. Additionally, 
CNCC migration is disturbed as ectopic cells are found in the dorsal neuroepithelium. These 
defects eventually result in craniofacial skeleton malformations. Interestingly, knock-down of 
Sost, a putative inhibitor of Lrp5 leads to similar defects suggesting that Wnt signaling levels 
need to be tightly balanced. To date both factors have mainly been associated with bone 
metabolism in man and mammals. This is the first report about an involvement in early 
morphogenetic processes, which might represent a teleost specific function.   
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The process of bone development is called osteogenesis. The skeleton derives from three distinct 
lineages. The somites give rise to the axial skeleton consisting of the vertebral column and the 
ribs (Tam and Trainor, 1995). The limb skeleton is generated by the lateral plate mesoderm (Cohn 
and Tickle, 1996) whereas the cranial neural crest is the origin of craniofacial bones such as skull 
and maxilla (Bronner-Fraser, 1994; Noden, 1991).  
Two mechanisms of bone development are distinguishable: Intramembranous and endochondral 
ossification. Intramembranous ossification, which occurs in the skull for instance, is the direct 
conversion of mesenchymal tissue into bone. The second process is more complex and comprises 
an intermediate step of cartilage formation which acts as a mould for subsequent ossification 
(Horton, 1990; Erlebacher et al., 1995). In more recent vertebrates all mesoderm-derived bones 
(vertebral column and limbs) are formed by this process.  
Mesenchymal cells proliferate as a consequence of interaction with epithelial cells which release 
differentiation factors such as bone morphogenic protein (BMP)-signals (St Amand et al., 2000). 
They condensate into compact nodules and subsequently differentiate to osteoblasts. This process 
is promoted by Core binding factor a1 (Cbfa1) also called Runt-related transcription factor 2 
(Runx2) which activates other osteoblast-specific genes encoding extracellular matrix-proteins 
(Komori et al., 1997). Another key regulator of osteoblast differentiation is the transcription 
factor Osterix (Osx, Nakashima et al., 2002). By secretion of a collagen-proteoglycan osteoid 
matrix and embedding of calcium, osteoblasts manage to assemble bone mass. Some oteoblasts 
become trapped into the calcified matrix and are subsequently called osteocytes. The surrounding 
mesenchymal cells form a membrane called periosteum. Inside this membrane further osteoblasts 
deposit matrix to form additional layers of bone.  
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The skeleton is in an incessant process of remodeling also called bone homeostasis. Bone mass is 
constantly added by osteoblasts and simultaneously degraded by osteoclasts. These cells derive 
from macrophage precursors and are translocated via blood vessels to the bones. They solubilize 
the bone matrix by pumping H+-Ions out of the cell and thereby acidifying the surrounding 
material. Osteoblast and osteoclast formation as well as activity is in a sensitive equilibrium.  
 
1.2. Zebrafish and medaka as models for bone research 
Most of the previous descriptions are based on experiments in mouse and chicken. More recently, 
however, zebrafish and medaka have become important models for bone research. It has been 
shown that key mechanisms and regulators of bone development are highly conserved among 
vertebrate species including teleosts and tetrapods (reviewed by Renn et al., 2006). The two types 
of bone development namely intracellular and endochondral/perichondral ossification are present 
in fish (Langille and Hall, 1987; Bird and Mabee, 2003) as well as the bone remodeling process 
resulting from the interplay between osteoblasts and osteoclasts (Witten et al., 2000 and 2001). 
Zebrafish but not medaka seems to develop cellular bone with osteocytes trapped inside the 
matrix (Ekanayake and Hall, 1987; Witten et al., 2001). The similarities on the cellular level are 
also reflected on the molecular level. Genes involved in osteogenesis in fish are characterized by 
a high homology in amino acid sequence and expression pattern with their tetrapod counterparts 
(reviewed by Renn et al., 2006).  
Thus, fish represent an excellent tool for basic research on issues of skeletal development and 
disease. This is because both medaka and zebrafish provide numerous advantages for this type of 
research: They frequently produce high numbers of offspring which develop rapidly and allow 
reproducibility of experimental settings and real-time analysis of development. The transparency 
of the embryos together with the development of new imaging strategies allow direct in vivo 
observation of developmental processes at the cellular level. The genomes of both species are 
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almost completely sequenced and publicly available. Although strategies of forward genetics are 
still challenging, both species are accessible for tools of genetic modification enabling generation 
of transgenic fish with tissue specific expression of reporters or functional proteins. A growing 
number of transgenic lines are maintained by the global research community.  
 
1.3. The development of the vertebral column 
During embryonic development of mammals and birds, the vertebral column is assembled by 
populations of mesenchymal cells that migrate around the notochord. They originate from the 
sclerotome which is part of the embryonic mesodermal somites (Christ et al.,2004). Subsequently, 
these mesenchymal cells undergo differentiation into chondrocytes and bone forming cells 
(osteoblasts) and eventually assemble the mineralized vertebrae by endochondral ossification. The 
vertebra contains the centrum, as well as the neural and hemal arches. Any failure in osteoblast 
differentiation results in the absence of mineralized vertebrae (Chan et al., 2007; Nakashima et 
al., 2002). Prior to calcification, a transient cartilage scaffold composed of segmented vertebral 
bodies (centra) is formed that follows the spatial information established by the somitic 
boundaries. Experiments in mouse mutants with defects in genes that are crucial for 
somitogenesis showed that such embryos fail to develop a segmented vertebral column (Chan et 
al., 2007; Kanda et al., 2007). 
In teleosts in contrast, the vertebrae are directly calcified without involvement of a cartilage 
scaffold, except in the anterior most neural arches that constitute the Weberian apparatus in some 
species, e.g. zebrafish (Bird and Mabee, 2003). A central role for the notochord in centra 
mineralization was proposed by Fleming and colleagues (Fleming et al., 2004), who showed that 
the zebrafish notochord, when isolated and cultured, is capable of secreting mineralized matrix on 
its own without involvement of recruited osteoblasts. These authors also demonstrated that local 
ablation of notochord cells resulted in the absence of centra mineralization in this region. For 
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Atlantic salmon it was reported that notochord cells juxtaposed to forming centra exert Alkaline 
Phosphatase activity, which is a marker for mineral secreting activity (Grotmol et al., 2005). 
Inohaya and colleagues (Inohaya et al., 2007) showed that a mineralized chordal centrum is 
formed from the notochordal sheath, an acellular layer that surrounds the notochord, before 
differentiation of sclerotome derived osteoblasts. However, they proposed osteoblasts to be the 
main source of subsequent mineralization.  
The teleost vertebral column seems to be pre-patterned independently from somites as suggested 
by observations made in fused-somite (tbx24) mutant zebrafish (Nikaido et al., 2002). These 
mutants are characterized by a disrupted anteroposterior identity of their somites and therefore an 
unorganized sclerotome pattern. Nevertheless, the centra still organize in a normal fashion while 
neural and hemal arches grow severely disorganized (van Eeden et al., 1996). This might suggest 
an instructive property of the notochord with possible contribution from the floor plate (Inohaya 
et al., 2010). However, the mechanism by which the notochord establishes a possible metameric 
pattern independently from somitic boundaries, yet in absolute congruence, is unknown. 
Osteoblasts are involved in the formation of vertebral bodies in medaka (Inohaya et al., 2007). 
Sclerotome derived cells around the notochordal sheath differentiate into osteoblasts and secrete 
extracellular bone matrix to build up the perichordal centrum, the bony layer around the chordal 
centrum. Osteoblast differentiation also occurs in the intervertebral region. Hence, at least two 
classes of osteoblasts are hypothesized (Inohaya et al., 2007). Class I cells are osteoblasts at the 
anterior and posterior edges of the centra, which secrete bone matrix and thereby facilitate 
rostrocaudal growth of the vertebral bodies. Class II cells in contrast are involved in deposition of 
the extra elastica matrix and thereby prevent mineralization of the intervertebral regions (Inohaya 
et al., 2007). However, to date osteoblasts have not been shown to be indispensable for the 
formation of vertebral bodies in medaka.  
Osterix (Osx) is a zinc finger transcription factor and key regulator for the differentiation of pre-
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osteoblasts to osteoblasts, first shown in mouse (Nakashima et al., 2002). In medaka, osx is 
expressed in early osteoblasts preceding bone mineralization (Renn and Winkler, 2009). osx 
transgenic expression was observed in advance of mineralization of the neural and hemal arches 
and at the edges but not the core of the chordal centrum. Therefore, whether and how osterix-
expressing osteoblasts contribute to the segmentation of vertebral bodies remains unclear.  
 
1.4. Cranial neural crest cells and their derivatives in the craniofacial skeleton 
“Of all the major vertebrate embryonic tissues, the neural crest is perhaps the most fascinating.” 
This quotation by Langeland and Kimmel (1997) reflects the astonishing potential of different cell 
fates this lineage is able to give rise to. Therefore, it is sometimes even called “the fourth germ 
layer”. Mostly depending on the region where the neural crest cells (NCCs) will migrate to, their 
fate will be to differentiate into different cells and tissues such as neurons of the enteric and 
peripheral nervous system, endocrine and paraendocrine derivatives and pigment cells. Cells from 
the cranial neural crest (CNCCs) mostly give rise to facial cartilage, bone and connective tissue. 
NCCs are specified at the neural plate-epidermis boundary upon induction by several paracrine 
factors such as BMPs, Wnts and FGFs. These factors trigger expression of a set of transcription 
factors (TFs) called the “neural plate border specifiers” (Meulemans and Bronner-Fraser, 2004). 
Their function is to prevent the region from becoming neural plate or epidermis and to activate 
expression of another set of TFs called “neural crest specifiers”. Committed NCCs undergo an 
epithelial to mesenchymal transition (EMT) and delaminate from the neural plate. Subsequently 
CNCCs migrate ventrally from regions anterior to hindbrain rhombomere 8 into the pharyngeal 
arches and the frontonasal process. Three characteristic major streams can thereby be 
distinguished (Fig. 1AB; reviewed by Kimmel et al., 2001). 1. The mandibular stream: CNCCs 
from the midbrain and rhombomere 1 and 2 migrate to the first pharyngeal arch (Fig. 1A, blue 
arrows). These cells will eventually form the most anterior jaw bones, the Meckel’s Cartilage and 
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the palatoquadrate (Fig. 1C, blue elements). 2. The hyoid stream: Cells adjacent to rhombomere 4 
migrate into the second pharyngeal arch and will later establish the basihyal, ceratohyal and the 
hyosymplectic (Fig. 1A, red arrows; C, red elements). 3. The branchial streams: The 3rd till 6th 
pharyngeal arches are invaded by CNCCs from rhombomeres 6 till 8 (only few in the 7th). Each of 
these five arches will give rise to one of the five ceratobranchials (Fig. 1A, green/yellow arrows; 
C, green/yellow elements). The mechanisms behind these complex processes are not yet 
understood. However, numerous publications indicate an important role of canonical Wnt 
signaling in this process (see chapter 1.5.). 
 
Fig. 1. Cranial neural crest cells and their craniofacial derivatives. (A) Three major streams of 
migrating CNCCs can be distinguished (drawing courtesy by Cheah Siew Hong). (B) dlx2a serves 
as marker for migrating CNCCs and enables to visualize cells in pharyngeal arches (from Lister et 
al., 2006 ). (C) Lateral and ventral schematic drawings of cranial skeleton, the color code matches 
the originating cells shown in A (from Kimmel et al., 2001). (D) Lateral and ventral views of 
larvae at 7 dpf stained with Alcian blue (cartilage)/Alizarin red (bone). Abbreviations: bb, 
basibranchial; bh, basihyal; cb, ceratobranchial; ch, ceratohyal; hb, hypobranchial; hs, 
hyosymplectic; ih, interhyal; M, midbrain; m, Meckel’s; pq, palatoquadrate; p, pharyngeal arch;. 
R, rhombomere. Anterior is to the left in all pictures. 
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1.4. The molecular basis of canonical Wnt signaling 
The family of Wnt molecules comprises several secreted lipid-modified glycoproteins (Willert et 
al., 2003). So far, 20 different wnt homologues have been described; 15 of them are also present 
in zebrafish (reviewed by Cadigan and Nusse, 2006). They are involved in numerous biological 
processes in embryonic development (Cadigan and Nusse, 1997; Wodarz and Nusse, 1998; Logan 
and Nusse, 2004) as well as in mature cell-cell signaling (Pinto and Clevers, 2005; Lowry et al., 
2005; Reya et al., 2003; Willert et al., 2003). Reduced activity of Wnt signaling is also associated 
with osteoporosis (Koay and Brown, 2005; Levasseur et al., 2005). There are several pathways 
for Wnt signaling (Veeman et al., 2003; Fanto and McNeill, 2004; Kohn and Moon, 2005) but the 
most important is signaling through β-catenin which is also called the “canonical Wnt pathway” 
(Fig. 2). Secreted Wnt molecules bind to the seven-transmembrane-span-protein Frizzled (Fz; 
Vinson et al., 1989). Together with Lrp5 or 6 they form a ternary complex on the cell surface (He 
et al., 2004; Pinson et al., 2000; Tamai et al., 2000; Wehrli et al., 2000; Zorn, 2001). This 
heterotrimeric complex leads to activation of Dishevelled (Dsh), a cytoplasmic protein that 
manages to inactivate the β-catenin destruction complex (Klingensmith et al., 1994).  
The detailed mechanism how the Wnt signal is transduced to inactivate the β-catenin destruction 
complex is not fully understood until now. This complex consists of GSK3β, axin and the tumor 
suppressor adenomatosis polyposis coli (APC; McCrea et al., 1991; Huber et al., 1997; Wieschaus 
and Riggleman, 1987).  
In the absence of Wnt, GSK3β phosphorylates β-catenin for ubiquitin-mediated degradation in the 
proteasome (Aberle et al. 1997). In the activated state of Wnt signaling, β-catenin remains stable 
(Hinck et al. 1994; Van Leeuwen et al. 1994) and translocates into the nucleus to form a complex 
with the HMG-Box containing transcription factors of the TCF-LEF-family. These factors 




Fig. 2. Schematic representation of canonical Wnt signaling: Left side shows active state by Lrp5 
mediated binding of Wnt ligand to Frizzled receptor and the signal transduction pathway. Right 
side shows Sost mediated inhibition of the pathway (adapted from van Bezooijen et al., 2008). 
 
1996; Korinek et al., 1997; Morin et al., 1997). Regulation of Wnt signaling mostly occurs in the 
extracellular region. Secreted Frizzled related proteins (sFRPs) as well as Wnt inhibitory factor-1 
(WIF-1) molecules both competitively bind to secreted Wnt molecules and therefore disable Wnt 
binding to Fz (Satoh et al., 2006; St-Arnaud and Moir, 1993). Other secreted inhibitors of Wnt 
signaling are SOST/sclerostin and Dickkopf (Dkk) (in association with Kremen) that both bind to 
Lrp5 and 6 and thereby prevent the formation of the heterotrimeric complex of Wnt, Fz and 
Lrp5/6 (Semenov et al., 2001 and 2005; Li et al., 2002).    
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1.5 Canonical Wnt signaling in neural crest cells  
A number of experiments revealed that canonical Wnt signaling is one of the crucial signal 
transduction pathways involved in all NCC related processes that take place in the course of 
development (reviewed by Raible and Ragland, 2005). It was shown that overexpression of 
several Wnt ligands or activated β-catenin results in expansion of the neural crest in Xenopus 
laevis (Wu et al., 2005 and references therein). In contrast, blocking of Wnt signaling by miss-
expression of GSK3β, dominant-negative Wnt8, truncated Tcf3, mutated Dishevelled or Nkd 
resulted in disruption of neural crest formation. Thus, Wnt signaling is important for induction of 
NCCs. In zebrafish, Wnt8 Morpholino knock-down blocks early NCC induction and a critical 
phase for NCC induction has been determined by expression of truncated Tcf under control of an 
HSP70 heatshock promoter (Lewis et al., 2004). Wnts also regulate proliferation and subsequent 
delamination of NCCs from the dorsal neuroepithelium (Burstyn-Cohen et al., 2004). A role in 
migration has also been suggested since LiCl2-mediated GSK3β inhibition prevents cell migration 
and blocks cell-matrix adhesion in cultured neural crest cells (de Melker et al., 2004). In Xenopus 
laevis, a role for Lrp6 has been suggested for NCC induction since its miss-expression expands 
the neural crest. Vice versa, excess transcripts of a truncated dominant-negative form of Lrp6 
seem to reduce the neural crest (Tamai et al., 2000). In contrast, Lrp6 does not seem to have a 
function for CNCCs in zebrafish as knock-down of this gene affects somitogenesis but does not 
result in any morphological craniofacial defects (Willems and Gajewski, unpublished; Willems, 
Diplomathesis, University of Cologne, 2007). 
 
1.6. The Wnt-coreceptor Lrp5 and its putative inhibitory ligand Sost  
The single-transmembrane-span-protein Lrp5 together with the closely related Lrp6 forms a new 
subfamily of low-density lipoprotein (LDL) receptor-related proteins (Nykjaer and Willnow, 
2002; Strickland et al., 2002). Arrow is the Drosophila ortholog with a sequence identity of 40% 
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(Pinson et al., 2000; Tamai et al.,2000; Wehrli et al., 2000). All LDL receptors show structural 
similarities, which are most prominent in the extracellular portion of the proteins. There are 
several Cys-rich LDLR binding repeats as well as Cys-rich EGF-repeats with associated spacer 
domains containing YWTD-propeller motives (Krieger and Herz, 1994). Lrp5 carries five repeats 
of the PPPSP motif in the intracellular region that are suggested to serve as phosphorylation 
targets (Zeng et al., 2005). These motives are unique to Lrp5/6 and not found in other receptors of 
the LDLR family. Lrp5 and 6 serve as co-receptors for Wnt ligands (He et al., 2004; Pinson et al., 
2000; Tamai et al., 2000; Wehrli et al., 2000; Zorn, 2001). Recent research on Lrps has led to 
some new suggestions how the Wnt signal is transduced into inactivation of the β-catenin 
destruction complex. The Lrp5/6 receptors appear to play a crucial part in this process. It has been 
shown that the intracellular domain of Lrp5/6 contains Axin2 binding sites (Mao et al., 2001). 
Thus, binding of Axin might be the trigger for inactivation of the phosphorylation of β-catenin. 
The binding sites are five reiterated PPPSP motifs mentioned before that need to be 
phosphorylated for Axin2 recognition (Tamai et al., 2004). A membrane associated form of 
GSK3β was recently suggested to phosphorylate Lrp5/6 upon stimulation by Fz (Zeng et al., 
2005). It was also shown that the intracellular domains of Lrp5/6 alone constitutively activate the 
pathway suggesting that the extracellular domain exerts a suppressing function (Mao et al., 2001a; 
Mao et al., 2001b; Liu et al., 2003).  
Sost is a secreted ligand that belongs to the family of Cysteine-knot proteins. It was identified as a 
member of the DAN (differential screening–selected gene aberrant in neuroblastoma) family of 
glycoproteins (Balemans et al., 2001; Brunkow et al., 2001). Other members of this family have 
been shown to be BMP antagonists, though in this respect, Sost seems not to be a classical 
member of this family (van Bezooijen et al., 2004). Sost inhibits Wnt signaling similar to other 
Dan proteins. In particular, Wise shares high homology with Sost (Ellies et al., 2006). The 
mechanism how Sost antagonizes Wnt is by binding directly to both Lrp5 and Lrp6 apparently 
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without competing for binding to Wnt ligands (Li et al., 2005; Semenov et al., 2005; van 
Bezooijen et al., 2007). One of the three cys-knot loops of Sost carries several positively charged 
residues, which are predicted to bind to a matching motif with negatively charged residues on the 
first β-propeller of Lrp5 (Veverka et al., 2009; Weidauer et al., 2009). A predicted Heparin 
binding site on Sost suggests Heparin mediated surface localization, which might facilitate 
receptor binding (Veverka et al., 2009).  
 
1.7. The role of Lrp5 and Sost in bone homeostasis of more recent vertebrates 
LRP5 appears to play a major role in regulation of bone mass, which is reflected by the finding 
that mutations in LRP5 are associated with the autosomal recessive osteoporosis-pseudoglioma 
syndrome (OPPG; Gong et al., 2001). Patients suffering from this syndrome are characterized by 
an early onset of osteoporosis and therefore high risk of fracture from early childhood on. It was 
reported in mouse that loss-of-function mutations in Lrp5 result in reduced proliferation of 
osteoblast precursors despite normal expression of Cbfa1, a key regulator of osteoblast 
differentiation (Kato et al., 2002). In contrast, there are several gain of function mutations of 
LRP5 that are all located in the first β-propeller domain and lead to a high bone mass phenotype 
(Boyden et al., 2002). The cause of this phenotype was later found to be due to the inability of 
binding Sost (Li et al., 2005; Semenov et al., 2005). 
Patients with loss-of-function mutations in the SOST gene suffer from sclerosteosis or van 
Buchem disease, both progressive sclerosing bone dysplasiae, comparable to gain of function 
mutations in LRP5 (Balemans et al., 2001 and 2002).  
So far in mammals, no link has been observed between mutations of LRP5 or SOST and severe 
developmental defects of the craniofacial skeleton. Nonetheless, there are reports about slight 
cranial bone dysmorphologies in human patients with gain of function mutations in LRP5, such as 
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craniosynostosys (Kwee et al., 2005) or a large lobulated torus palatinus and an abnormally thick 
mandibular ramus already at young age (Boyden et al., 2002). Patients suffering from loss-of-
function mutations in SOST are also characterized by abnormal cranial morphology such as a high 
forehead and a protruding large chin. However, these traits have been described to appear in a 
progressive manner over lifetime and do not suggest to be the cause of a developmental 
malfunction (Balemans et al., 2001).  
An earlier report by Yadav et al. (2008) challenged the established idea that LRP5 directly 
controls bone cells in order to maintain bone mass. These authors presented conclusive evidence 
that LRP5 exerts its effect on bone mass through regulating biosynthesis of Serotonin in the gut. 
However, a more recent report (Cui et al, 2010) shows that in mouse osteocyte specific activation 
of a gain of function variant of Lrp5 leads to high bone mass phenotype in a cell autonomous 
fashion, thus reverting the attention of Lrp5 function back on bone cells.  
A role in craniofacial development of non-mammalian vertebrate species is suggested by the 
expression pattern of lrp5 and lrp6 in Xenopus (Houston and Wylie, 2002). So far, functional 
studies have only been conducted on lrp6 in this species (Tamai et al., 2000). In the course of my 
diploma thesis I studied the function of zebrafish lrp6 which was shown to be indispensable for 
somitogenesis and trunk development but had no apparent role in craniofacial development 
(Willems and Gajewski, 2007). Thus, the question about a possible involvement of Lrp5 in 
zebrafish craniofacial development remained to be answered.  
 
1.8. Aim of the project 
The first aim of this project was to investigate the role of osteoblasts for the formation of the 
teleost vertebral bodies. For this, I generated transgenic medaka fish to express the nfsB-gene 
encoded Nitroreductase (NTR) from Escherichia Coli (Bryant et al., 1991) as a fusion protein 
with Cyan Fluorescent Protein (CFP) under the control of the osx-promoter, which was 
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characterized earlier in our laboratory (Renn and Winkler, 2009). NTR metabolizes the antibiotic 
Metronidazole (Mtz) into a DNA-crosslinking cytotoxic product. This approach has been 
successfully used for cell ablation in various organs in zebrafish, except bone (Curado et al., 
2008; Pisharath et al., 2007). By ablating osteoblasts and studying the consequences to the 
developing larva, I sought to gain new insights into the role of osteoblasts during development of 
the vertebral column. This study is the first of its kind showing successful application of the 
nitroreductase cell ablation technique in medaka. Furthermore, it is the first fish model for 
osteoporosis due to reduced numbers of osteoblasts. 
The second aim of the project was to study the function of Lrp5 and Sost during cranial neural 
crest development in zebrafish. A particular interest was to find out, whether and how these two 
genes contribute to the formation of the craniofacial skeleton. The functional diversity of Wnt 
signaling is reflected by a huge set of different ligands (15 Wnts in zebrafish) and receptors (11 
Fzs in zebrafish). However, there are only two types of co-receptors (Lrp5 and Lrp6) that are 
thought to be crucial for the function of canonical Wnt signaling. By knocking-down one of the 
co-receptors, I intended to abolish Wnt signaling more efficiently than by inhibition of single 
ligands or receptors. Since Lrp6 has been ruled out to be involved in craniofacial development of 
zebrafish, it seemed reasonable to analyze the role for Lrp5 in this organism.  
The interaction of Sost and Lrp5 has recently become a highly recognized field in bone related 
research. Due to its inhibitory function in the bone anabolic process and clinical relevance in 
humans, attempts are being made to target this interaction. By using the experimental advantages 
of the fish model, such as dose-dependent gene knock-down and dynamic bioimaging, I sought to 
gain better insight into the function and activities of the two proteins. This might eventually 
provide clues that could contribute to the overall aim to treat and prevent bone related diseases 
such as osteoporosis, which have become a major public health concern in our ageing society. 
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2. MATERIALS AND METHODS	  
2.1 Materials 
2.1.1. Zebrafish and medaka strains and transgenic lines 
The medaka OI wild-type strain from the Department of Biological Sciences (DBS) was used as 
well as transgenic osx:mCherry fish (Renn and Winkler 2009). For zebrafish experiments, DBS 
wild-type fish as well as transgenic sox10:GFP (Dutton et al., 2008), fli1:EGFP (Lawson and 
Weinstein, 2002) and TOPdGFP zebrafish (Dorsky et al., 2002) were used. All experiments were 
performed in accordance with the IACUC protocols of the National University of Singapore 
(approval numbers 020/08, 014/11). 
 
2.1.2. Morpholino oligonucleotides 
For gene knock-down experiments, lrp5 as well as sost splice site Morpholinos were synthesized 
by Gene Tools (Corvalis, OR). For knock-down of lrp5, I designed the “lrp5MoUp” Morpholino 
(5’-AGCTGCTCTTACAGTTTGTAGAGAG-3’) to match to the Exon2-Intron2 splice site and 
the “lrp5MoDown” Morpholino (5’-CCTCCTTCATAGCTGCAAAAACAAG-3’) to cover the 
Intron2-Exon3 splice site (see Fig. 16A). A mismatch morpholino with 5 base substitutions 
“lrp5MoUpMM” (5’-AGgTGCTgTTAgAGTTTcTAGAcAG-3’) was designed as control. For 
knock-down of sost, the two splice site Morpholinos “sostMoUp” (5’-
TCACGTTACTTACCATAAGTCCGTG-3’) and “sostMoDown” (5’-
GTTCTGAGGCTCCTGGGAAAGAAAG-3’) were designed  to match to the splice donor and 
acceptor site of the only intron in the sost gene. Also for sost knock-down, a mismatch 
morpholino with 5 base substitutions “sostMoUpMM” (5’-
TCACcTTAgTTAgCATAAcTCgGTG-3’) was designed as control. Sequence information for 
p53 control Morpholino (5’-GCGCCATTGCTTTGCAAGAATTG-3’) was taken from Robu et 
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al. (2007). 3 mM stock solutions were prepared by dissolving the lyophilized Morpholinos in 
100µl millipore water.  
2.1.3. Primers 
Primers were designed using the online application Primer3 (v. 0.4.0; 
http://frodo.wi.mit.edu/primer3/) and synthesized by 1st Base (Singapore). Being delivered in 
lyophilized condition, primers were dissolved in an appropriate volume of TE buffer to a final 
concentration of 100 µM. For working solutions, primers were further diluted 1/10 in TE-buffer 
All used primers are listed in table 2.1.  
 
Table 2.1. List of used primers. 
# Name Sequence 
for subcloning of osx:CFP-NTR (see. 2.3.5.1.) 
1 LinkerBamSmaSalNotA 5’-GATCCCCCGGGAGATACAGTCGACGC-3’  
2 LinkerBamSmaSalNotB 5’-GGCCGCGTCGACTGTATCTCCCGGGG-3’ 
for PCR amplification of riboprobe templates (see 2.3.5.2.) 
3 Lrp5up1 5’-CCATCAAACAGACCTACTACAACCT-3’  
4 Lrp5down1 5’-GAATATCATTGACTTGAAGGACGAT-3’ 
5 Sostup 5’-CCAGATCTCCACCATGCAGGTGTCTCTGGCGCT-3’  
6 Sostdown 5’-GGCTCGAGGGTCAGTATGAATTGCTGTTGA-3’ 
7 crestinup 5’-GCCAAGATGTTCACGCCTAT-3’  
8 crestindown 5’-GTTGCATCAAGGTGGTGTTG-3’  
for validation of Morpholino mediated knock-down by RT-PCR (see 2.3.5.3.) 
9 Lrp5MoChkup 5’- CAGTGGACTTTCTCTTCTCG-3’ 
10 Lrp5MoChkdown 5’- GTCTCCGAGTCAGTCCAGTA-3’ 
11 Lrp5MointronChkdown 5’- CTAAGATTGTGGGTCACAGG-3’  
12 SOSTExon1up 5’- TGCTTCAGGGATGTTTCACA-3’ 
13 SOSTExon2down 5’- CGATTGGTTGTGTTGTCGAG-3’ 
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2.2. Fish treatment 
2.2.1. Fish keeping and husbandry 
Fish were kept in the department’s fish facility. To obtain embryos, fish were kept on a 14h/10h 
day/night cycle and crossed in mating tanks. Embryos were kept in petri dishes with 1x Danieau’s 
solution (17.4 mM NaCl, 0.21 mM KCl, 0.12 mM MgSO4, 0.18 mM Ca(NO3)2, 1.5 mM HEPES, 
pH 7.6). To prevent pigmentation, 0.003% 1-phenyl-2-thiourea (PTU) was added to the medium 
starting from 8 to 10 hours post fertilization (hpf). Staging was done according to Kimmel et al. 
(1995).  
2.2.2. Morpholino injection  
For injections, Morpholino oligonucleotide (Mo) stock solutions were diluted in H2O with 0.1% 
Phenol Red. Working solutions were loaded into glass capillaries that were previously prepared 
with a needle puller (Narishige) to yield a sharp tip. Injection was performed by inserting the 
needle into the yolk of the embryo at a position slightly underneath the cell. Mo solution was 
released into the yolk of one- or two-cell stage embryos by means of air pressure supplied from a 
FemtoJet® Microinjector (Eppendorf).  
2.2.3. Mechanical dechorionation of zebrafish 
Before fixation, older embryos were mechanically dechorionated to guarantee a straightened body 
axis for subsequent experiments. Therefore, chorions were carefully opened and removed by 
means of fine-pointed watchmaker’s forceps. Embryos younger than 24 hpf were dechorionated 
after fixation.   
2.2.4. Chemical dechorionation of medaka 
To dechorionate embryos before natural hatching, a protocol based on Pronase treatment was 
carried out (modified from Villalobos et al. 2000). Embryos were incubated in 0.6 mg/ml 
Pronase® (Boehringer Mannheim, Indianapolis, IN) dissolved in dechorionation buffer (50 mM 
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glycine, pH 9±0.3, Sigma in 1x Danieau’s solution) at 30°C for 3-4 hours. Subsequently, 
dechorionated embryos were rinsed several times in 1x Danieau’s solution. Remaining chorions 
were removed manually using forceps. 
2.2.5. Mtz treatment 
For targeted cell ablation, osx:CFP-NTR and control medaka were incubated in 10 mM 
Metronidazole (Sigma) dissolved in Danieau’s solution with 0.1% DMSO. Throughout the 
incubation period, larvae were kept in 6-well plates at 30°C in the dark. Media were replaced 
once a day. The control larvae were kept in 0.1% DMSO in 1x Danieau’s solution. 
2.2.6. SU5402 treatment  
For SU5402 treatment, zebrafish embryos were manually dechorionated with forceps and placed 
in 24-well plates. SU5402 stock solution (1.44 mM in DMSO) was dissolved in Danieau’s 
solution to a final concentration of 10µM. Control embryos were kept in the same DMSO 
concentration (6.9%). Embryos were kept in the solution for 3 hours between 16 hpf (14 somite 
stage; ss) to 19 hpf (20ss). Subsequently, embryos were rinsed three times in Danieau’s solution 
and fixed in 4% PFA. 
2.2.7. Fixation of embryos and larvae 
At desired stages, embryos and larvae were fixed in 4% paraformaldehyde (PFA)/phosphate 
buffered saline (1 M NaCl, 19.5 mM KCl, 59 mM Na2HPO4, 11 mM KH2PO4) plus 0.1% Tween 
(PBST) for at least 4 hours or overnight. Subsequently embryos/larvae were washed 3 times for 5 
minutes in PBST followed by one wash in methanol and finally storage in methanol at -20°C 
2.3. Molecular Biology protocols and applications 
2.3.1. RNA extraction 
To extract total RNA from zebrafish embryos, the RNeasy-Kit (Qiagen) was used as follows: 
Around 30 embryos at the desired stage were transferred into a 1.5ml reaction tube and 
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homogenized with a pestil in 350μl RLT-buffer followed by a centrifugation step. The 
supernatant was transferred to a new reaction tube and 350μl 70% ethanol were added. The 
solution was transferred to a spin column and centrifuged at >8,000xg for 15 seconds. The flow 
through was discarded and after addition of 700μl RW1 buffer a centrifugation was carried out 
again at >8,000xg for 15 seconds. The flow through was discarded and after addition of 500μl 
RPE buffer another centrifugation was carried out again at > 8,000xg for 15 seconds. This step 
was performed twice with a 2 minute centrifugation step before the column was placed into a 
fresh tube and centrifuged for 2 minutes to discard all traces of liquid. For elution of RNA the 
column was placed into a new reaction tube and centrifuged 2 times with 30μl RNase-free H20. 
To remove traces of genomic DNA 2μl RNase free DNase (Fermentas) were added and the 
solution was incubated at 37°C for 30 minutes. Subsequently, the RNA was cleaned up by 
phenol:chloroform extraction.  
2.3.2. Phenol:chloroform extraction  
Phenol:chloroform extraction was done to remove proteins from nucleic acid solutions. An equal 
volume of phenol:chloroform was added to the DNA/RNA protein mixture and vigorously 
vortexed for 30 seconds. It was then centrifuged at 13,000xg for 1 minute. With a glass pasteur 
pipette, the aqueous phase was transferred into a fresh reaction tube and the organic phase was 
discarded. Subsequently, an equal volume of chloroform was added to the sample, vortexed for 30 
seconds and centrifuged at 13,000xg for 1 minute. Afterwards, the aqueous phase was transferred 
to a new reaction tube for ethanol precipitation.  
2.3.3. Ethanol precipitation 
Ethanol precipitation was performed to concentrate the DNA: 1/10 volume 3M NaOAc and 2.5 
volumes Ethanol (100%) were added to the solution. The DNA was precipitated for ≥2 hours at -
20°C. This was followed by a centrifugation step at 13,000xg for 30 minutes at 4°C. The pellet 
was washed using 70% ethanol and again centrifuged at 13,000xg for 5 minutes. Then the ethanol 
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was removed and the pellet was allowed to dry for 5 minutes before it was resuspended in H20.  
2.3.4. cDNA synthesis 
cDNA was synthesized from 0.1-5µg extracted and purified total RNA (2.3.1.) using the First 
Strand cDNA Synthesis Kit (Fermentas). RNA was diluted with H2O to a volume of 11µl and 1µl 
of random hexamer primer was added. For annealing the solution was incubated at 70°C for 5 
minutes and subsequently chilled on ice to prevent folding of RNA secondary structures. After 
addition of 4µl 5x reaction buffer, 1µl RNase inhibitor (20 U/µl) and 2µl dNTPs (10 mM) the 
reaction was incubated at room temperature for 5 minutes. 1ul reverse transcriptase (200U/µl) 
was added to start the reaction first at room temperature for 10 minutes, then at 42°C for 1h. To 
stop the reaction, temperature was raised to 70°C for 10 minutes.  
2.3.5. Polymerase chain reaction (PCR)  
2.3.5.1. General protocol  
PCR was carried out to amplify DNA sequences (Mullis et al., 1986). For each reaction 1-100 ng 
template DNA were used. Furthermore 200 nM primer up, 200 nM primer down, 200 μM desoxy-
nucleotide triphosphate (dNTP)-mixture (Fermentas), 1/10 volume 10× reaction buffer 
(Fermentas) and 0.2μl of Taq DNA Polymerase (Fermentas; 5 units/μl) were added to each 
reaction. The total volume of the reaction was 25μl.  
The reactions were performed in a VeritiTM-96Well Thermal Cycler (Applied Biosystems) or a 
Tpersonal Thermal Cycler (Biometra) choosing the following conditions: Initial denaturation of 
DNA took place at 95°C for 5 minutes. At the beginning of a cycle, there were 30 seconds of 
denaturation at 95°C followed by annealing of the primers for 30 seconds at 55°C (the annealing 
temperature was adjusted depending on the sequence of the primer used). Extension took place at 
72°C for 30 seconds (elongation time was adjusted depending on the expected fragment size; 1 
minute/kb). The cycle was repeated 25 times followed by a terminal heat step at 72°C for 7 
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minutes. The obtained PCR products were then run on an agarose gel. 
2.3.5.2. PCR amplification of riboprobe templates 
Zebrafish wild-type cDNA was used for riboprobe template cloning. The lrp5 gene sequence is 
available at Ensembl (ENSDARG00000006921). According to this sequence, primers “Lrp5up1” 
and “Lrp5down1” were designed to PCR-amplify a 885 bp fragment. According to a zebrafish 
sost sequence available in Ensembl (ENSDARG00000061259), the full length open reading 
frame (orf) of sost was PCR-amplified with primers “Sostup” and “Sostdown”. Crestin antisense 
probe template was PCR amplified with the primers “crestinup”: and “crestindown”, which 
yielded a 802 bp fragment. All other riboprobe templates were provided by colleagues and 
collaborators.  
2.3.5.3. Validation of Morpholino mediated knock-down by RT-PCR 
To assess the efficiency of the knock-down approaches at the transcript level, cDNAs from 25 ss 
wild-type control as well as morphant embryos was used. Correctly spliced transcripts were PCR 
amplified using the primers “Lrp5MoChkup” and “Lrp5MoChkdown” (Fig. 16A). To amplify 
transcripts retaining introns due to morpholino mediated splicing deficiency, the primers 
“Lrp5MoChkup” and “Lrp5MointronChkdown” were used. Likewise, to quantitatively check for 
correctly spliced sost transcripts, the primer combination “SOSTExon1up” and 
“SOSTExon2down” was used. PCR products were mixed with loading buffer and applied to gel-
electrophoresis.  
2.3.6. Agarose gel electrophoresis  
To separate nucleic acids depending on their size agarose gels were used. Gels were made by 
dissolving 1% agarose (1st Base) in 0.1M sodium borate (SB) buffer (pH 8.8) with CybrGreen 
(diluted 1:10,000; Invitrogen) and short boiling in a microwave oven. The solution was poured 
into a gel casting mold and allowed to harden at room temperature. 1/10 Volume 10× loading-
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buffer (Fermentas) was added to the samples which were pipetted into the molds of the gel. The 
gel was run with a current of 150-300 Volts in a horizontal flat bed gel chamber (BioRad) filled 
with 1x SB-buffer. Gels were analyzed on a G:BOX gel documentation system (Syngene) with 
GeneSnap software (Syngene). 
2.3.7. Extraction of DNA fragments from agarose gels  
After gel electrophoresis, the fragment of interest was cut from the gel using a scalpel and 
transferred into a 1.5 ml reaction tube. The actual extraction was done using the Gel/PCR DNA 
Fragments Extraction Kit (GeneAid) according to the manufacturer’s protocols.  
2.3.8. Restriction enzyme digestion of DNA  
Restriction enzyme digestion was used to cut DNA double-strands at defined consensus 
sequences. Depending on the experiment 1-5μg of DNA were digested in reaction volumes of 20-
100μl. Furthermore the reaction consisted of 1/10 Volume reaction buffer and 10-20U of the 
desired restriction enzyme (Fermentas) and was incubated for at least 2 hours or over night at 
37°C. Subsequent recovery of DNA was done by gel extraction (2.3.7) or a phenol:chloroform 
extraction (2.3.2).  
2.3.9. Cloning work 
2.3.9.1. General procedures 
20-40 ng of the vector DNA was used for ligation and the amount of the insert DNA was adjusted 
to a molar ratio of 4:1 to the vector. Additionally the ligation reaction contained 2ul 5X DNA 
Ligase Reaction Buffer, 0.5μl T4 DNA Ligase (1U/μl; New England Biolabs), 1μl ATP 
(Fermentas) and H2O to a final volume of 10μl. The reaction was incubated for 1hour at RT and 
was used afterwards to transform bacteria cells.   
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2.3.9.2 Cloning of osx:CFP-NTR plasmid 
The osx:CFP-NTR vector was created in two steps. First, mCherry was released from the I-SceI-
pBSII-SK plasmid containing the 4.1 kb osx promoter (Renn and Winkler, 2009) by digestion 
with BamHI and NotI and replaced with a short linker insert that contained the two additional 
restriction sites SmaI and SalI (after annealing the two oligonucleotides 
“LinkerBamSmaSalNotA” and “LinkerBamSmaSalNotB”). Then, a fusion construct of the nfsB 
gene and the gene encoding Cyan Fluorescent Protein (CFP) was isolated from the ins:CFP-NTR 
plasmid (kindly provided by D. Stanier; see Curado et al., 2008) by digestion with SmaI and SalI 
and ligated into the digested target vector. 
2.3.9.3 TOPO/pDrive cloning of riboprobe templates  
Purified PCR products of partial lrp5 and crestin transcripts were ligated into the pDrive cloning 
vector (Qiagen) by adding 100 ng of DNA to 5μl of Ligation Master Mix and 1μl of vector (50 
ng) and adjusting the total volume by addition of H20 to 10μl. After incubation for 30 minutes at 
4°C the reaction was ready for transformation.  
The sost PCR product was cloned into pCRII-TOPO (Invitrogen) by adding 4μl of PCR product 
(~100 ng) to 1μl of salt solution and 1μl vector (50 ng). After incubation for 5 minutes at room 
temperature the reaction was ready for transformation.   
2.3.10. Transformation of bacteria  
The ligation mix was transformed into chemically competent DH5α (Invitrogen) by heatshock. 
For this, aliquots of bacteria (100μl) were thawed on ice and after addition of various amounts of 
ligation reaction (2.3.9.) incubated on ice for 30 minutes. For the actual heatshock, bacteria were 
exposed to 42°C in a thermomixer (Eppendorf) for 30 seconds and put back on ice for another 2 
minutes. After addition of 900μl LB-medium bacteria were shaken at 37°C at 225 revolutions per 
minute (rpm) for 1h. Transformed bacteria were then plated on LB-agarose plates carrying the 
appropriate antibiotic resistance (Ampicilin or Kanamycin at 100 μg/ml) as well as 40μl IPTG 
 33 
(100 mM) and 80μl X-Gal (20 mg/ml) for blue white selection. The LB-agarose plates were 
incubated over night at 37°C.  
2.3.11 Preparation of plasmid DNA  
Using sterile pipette tips single clones were picked from the bacteria plates and transformed to 
vials containing 5 ml LB-medium with the required antibiotic in a concentration of 50 μg/ml. The 
culture was incubated overnight at 37°C in a thermoshaker (NFORS). The next day, plasmid 
preparation was performed using the High-Speed Plasmid Mini Kit (GeneAid) according to the 
provided manual.  
2.3.12 Sequencing of DNA  
DNA sequencing was carried out at the department’s DNA sequencing laboratory (DSL) with an 
ABI3130xl sequencer (Applied Biosystems) according to the dideoxy chain termination method 
(Sanger et al., 1977). Reactions were prepared using the BigDye® Terminator v3.1 Cycle 
Sequencing Kit (Applied Biosystems) according to the provided manual. Each reaction contained 
1-50ng DNA, 1μl Primer (3μM) and 2μl BigDye reaction premix, diluted with H2O to a total 
volume of 10μl.   
Reaction profile: Initial denaturation of DNA took place at 96°C for 1 minute at the beginning of 
a cycle. There were 10 seconds of denaturation at 96°C followed by annealing of the sequencing 
primer for 10 seconds at around 55°C (the exact annealing temperature depends on the sequence 
of the primer used). Extension took place at 60°C for 4 minutes. This cycle was repeated 25 
times. Subsequently, the reaction mix was diluted with H2O to 20μl and transferred to a 1.5ml 
reaction tube. For precipitation of DNA, 2μl EDTA (125 mM), 2μl NaOAc (3 M) and 50μl 
ethanol (100%) were added. After 15 minutes of incubation at room temperature, the tubes were 
centrifuged at 13,000xg for 30 minutes at 4°C. Then the supernatant was removed to allow the 
pellet to dry, which was then sent to DSL for the actual sequencing process. The obtained 
sequence files were analyzed using BioEdit 7.0.5.2. 
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2.3.13 In vitro transcription to produce in situ probes  
For digoxigenin (DIG) or fluorescein (FLU)-labeled riboprobes, plasmids were linearized with 
restriction enzymes. Subsequently, in vitro transcription was performed with RNA polymerase 
(Fermentas) and DIG/FLU-RNA labeling Mix (Roche).  
The transcription reaction contained 1μg of linearized plasmid DNA, 2μl 10× Labeling Mix, 2μl 
RNA Polymerase (20 U/μl), 4μl 5x Transcription-buffer and 1μl Ribolock RNase Inhibitor (40 U 
/μl, Roche, Mannheim). The total volume was adjusted to 20μl with H2O.. The reaction was 
incubated at 37°C for 2 hour and subsequently incubated another 15 min at 37°C with 1μl RNase 
free DNaseI (10 U/μl; Fermentas) to remove the template DNA. Purification of the transcripts 
was done by ethanol precipitation with 1/10 Volume LiCl2. The RNA pellet was dissolved in a 
mixture of 25μl H20. One µl was used for quality analysis by gel electrophoresis while the other 
24μl were dissolved in 76μl hybridization mix and stored at -30°C. 
Riboprobes were generated with the following combination of linearizing restriction enzyme and 
Polymerase: osc: BamHI/T7 RNA-Polymerase (FLU labeled; all others DIG labeled); lrp5: 
XhoI/T7 RNA-Polymerase; sost: NotI/T7 RNA-Polymerase; gfp: HindIII/T7 RNA-Polymerase; 
lef1: NotI/SP6 RNA-Polymerase; ccnd1: BamHI/T7 RNA-Polymerase; dlx2a: BamHI/T7 RNA-
Polymerase; foxd3: BamHI/T7 RNA-Polymerase. Additional plasmids were kindly provided by 
Dr. Joerg Renn (NUS), Dr. Thuy Thanh To (NUS), Dr. Jan Brocher (NUS) and Dr. Cheah Siew 
Hong (NUH).  
2.4. Generation of osx:CFP-NTR medaka 
To generate transgenic medaka, the circular plasmid was injected into one-cell stage embryos 
using the ISce-I meganuclease technique (Rembold et al., 2006). Injected fish were selected for 
osteoblast specific CFP signal, raised and crossed to wild-type fish to identify germline 
transmitting founders. Intercrossing F1 transgenic fish yielded homozygous F2 embryos 
according to Mendelian ratios of inheritance.  
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2.5. Staining assays 
2.5.1. Whole-mount in situ hybridization 
To analyze patterns of gene expression I stained transcripts by means of in situ hybridization. 
Fixed embryos were rehydrated in descending dilutions of methanol in H2O (75% - 50% - 25%) 
each step lasting 5 minutes. After a wash in PBST embryos were subjected to Proteinase K 
treatment to further perforate the cell membranes to ensure best conditions for riboprobe 
penetration. For this, embryos were incubated in 10 μg/ml Proteinase K (Roche; diluted in PBST). 
The duration of this step was depending on the developmental stage of the embryos and done 
according to Thisse and Thisse (2008). The reaction was stopped by two washes in 1x glycine 
(200 µl 50x glycine/10 ml PBST) and refixation in 4% PFA for 20 minutes. After that, embryos 
were washed five times for 5 minutes in PBST to remove traces of PFA.  
For prehybridization embryos were incubated in hybridization mix (50% formamide, 5x SSC, 150 
μg/ml Heparin, 5 mg/ml torula RNA, 0.1% Tween) for 1 hour at 65°C in a waterbath. For the 
actual hybridization step, embryos were incubated in riboprobes diluted 1:100 in hybridization 
mix at 65°C in a waterbath over night. The next day, riboprobe solutions were removed and 
stored for future experiments. Embryos were washed twice for 30 minutes at 65°C in 50% 
formamide/2x SSCT followed by one wash for 30 minutes at 65°C in 2x SSCT and another two 
washes for 30 minutes at 65°C in 0.2x SSCT. Then, one wash in PBST for 5 minutes took place at 
room temperature.  
For antibody binding, embryos were blocked for 1 hour in 5% sheep serum/PBST at room 
temperature before they were incubated for 2 hours in preabsorbed sheep anti-DIG/anti-FLU Fab-
fragments coupled with alkaline phosphatase (Roche) diluted 1:2000. After that, embryos were 
washed at least five times in PBST whereby one wash step was carried out over night to ensure 
removal of all unbound antibodies.  
At the third day, staining was performed by incubating embryos two times for 5 minutes in 
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prestaining buffer (0.1 M NaCl, 0.05 M MgCl2, 0.1 M Tris-HCl pH9.5, 0.1% Tween) to adjust the 
conditions for enzymatic reaction of alkaline phosphatase. As substrate BM-Purple (Roche) was 
used and incubation lasted for several hours in the dark until color reaction was detectable. To 
stop the reaction embryos were washed several times in PBST and stored in 4%PFA. The 
procedure was carried out in 24-well plate format according to Thisse and Thisse (2008).  
2.5.2. Immunohistochemistry  
Immunohistochemistry was carried out by rehydrating fixed embryos in descending dilutions of 
methanol in H2O (75% - 50% - 25%). Subsequently, embryos were kept in PBDT (1% DMSO, 
1% BSA, 2.5% sheep serum and 0.1% TritonX in PBST) for 1 hour and incubated in primary 
antibody solution (diluted in PBDT) over night. On the second day, embryos were washed four 
times for 1 hour in PBST/0.1% TritonX and incubated with the secondary antibody (diluted in 
PBDT) over night. On the third day, embryos were washed four times for 1 hour in PBST/0.1% 
TritonX. After binding with fluorescent dye labeled antibodies, embryos were ready for imaging. 
When stained with biotinylated antibodies, embryos were subjected to further processing 
following the Vectastain (Vector Laboratories Inc., Burlingame CA) protocol: A mix of 1 drop of 
solution A and 1 drop of solution B was incubated in PBS for 30 minutes before it was used to 
incubate embryos for 1 hour at room temperature to bind a peroxidase to the antibody . 
Subsequently, embryos were washed four times for 30 minutes in PBST/0.1% TritonX. Then 
embryos were stained with 3,3’-Diaminobenzidine (DAB). A Sigma FastTM DAB Tablet (Sigma) 
was dissolved in 5ml H20 and embryos were pre-incubated with that solution for 30 minutes. 
Then, a Sigma FastTM DAB Tablet was diluted in 5ml H20 together with a Urea/H2O2 tablet. 
Incubation of embryos in this solution yielded a color reaction after few minutes. 
 To stain for GFP positive cells a monoclonal mouse anti-GFP antibody (diluted 1:1000; 
Invitrogen) was used in combination with anti-mouse Alexa488 coupled antibody (diluted 1:1000; 
Invitrogen) or biotinylated anti-mouse antibody from the Vectastain ABC Kit (diluted 1:1000; 
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Vector Laboratories Inc., Burlingame CA) in combination with Sigma FastTM 3,3’-
Diaminobenzidine (DAB) Tablets (Sigma). To stain for mitotic cells, rabbit derived monoclonal 
anti-phosho-histone3 (pH3) antibody (diluted 1:1000; Upstate Biotechnology, NY) was used in 
combination with an anti-rabbit Alexa568 coupled antibody (diluted 1:1000; Invitrogen).  
2.5.3. Cell proliferation assay by analysis of BrdU incorporation  
To check for nuclei in S-phase, embryos were incubated in 10 mM BrdU for 30 minutes, washed 
several times and kept another 30 minutes before fixation in 4%PFA over night. On the following 
day, embryos washed several times in PBST and kept overnight in methanol absolute. For 
staining, embryos were rehydrated in descending dilutions of methanol in H2O (75% - 50% - 
25%), followed by incubation for 1 hour in 2N HCl at 37°C to expose the DNA. Subsequently, 
BrdU-positive nuclei were stained by immunohistochemistry (see 2.5.2.) using mouse anti-BrdU 
antibody (BSHB, Iowa City, IA; diluted 1:500 in PBDT) in combination with anti-mouse Alexa 
488 coupled secondary antibody (diluted 1:1000; Invitrogen). 
2.5.4. Histological staining  
This part was carried out by Dr. Ann Huysseune (Ghent University, Belgium). Embryos or larvae 
were rinsed in 0.1 M cacodylate buffer with 10% sucrose added, then postfixed for 2 hours in 1% 
OsO4 in 0.1 M cacodylate buffer to which 8% sucrose is added, rinsed again in 0.1 M cacodylate 
buffer, dehydrated through a graded series of ethanol, brought into propylene oxide and finally 
embedded in hard epon (epon A:B mixed 2:3, according to Luft, 1961). Serial transverse sections 
of 1 µm were prepared using a diamond knive mounted on a Prosan HM 360 microtome, stained 
with toluidine blue and mounted with DPX mountant  (Sigma). They were viewed under 
transmitted light on a Zeiss  AxioImager Z1. Photographs were taken with a Zeiss Axiocam 




2.5.5 Cartilage and bone staining 
2.5.5.1. Dual-color acid-free cartilage and bone staining 
Dual-color acid-free cartilage and bone staining was carried out on 7 days post fertilization (dpf) 
larvae according to Walker and Kimmel (2007): Larvae were fixed in 4% PFA for 2h, washed in 
PBST and incubated in 50% ethanol for 10 minutes. Subsequently, larvae were incubated over 
night in staining solution consisting of 700µl ethanol, 200µl MgCl2 (0.5 M), 50µl Alcian Blue 
(0.4%), 40µl H20 and 10µl Alizarin Red (0.5%). On the next day, larvae were washed in H20 and 
bleached in 1% KOH/1.5% H2O2 for 20 minutes to remove pigmentation. A clearing step in 20% 
glycerol/0.4% KOH for 30 minutes made the tissue more transparent. For imaging, the 
viscerocranium was separated from the neurocranium by manual dissection with injection needles 
and mounted in glycerol on a microscopic slide with cover slip.  
2.5.5.2. Live skeletal staining 
For life skeletal staining, 0.01% Alizarin Complexone (ALC, Sigma) was dissolved in 1x 
Danieau’s solution and filtered through a 0.22µm pore size filter. Larvae were incubated in 
staining solution for 2 hours at 30°C in the dark. Subsequently they were rinsed several times in 
1x Danieau’s solution and mounted for microscopic imaging.  
2.5.6. Staining for apoptosis 
2.5.6.1. Acridine Orange staining  
To identify cell death in living organism, larvae were incubated for 20 min in 5 µg/ml Acridine 
Orange (Sigma) dissolved in 1x Danieau’s solution in the dark. Afterwards, larvae were washed 3 
times in 1x Danieau’s solution and mounted for imaging. 
2.5.6.2. TUNEL assay 
For TdT-mediated dUTP-biotin nick end labeling (TUNEL) assay, embryos were fixed in 4% 
formaldehyde over night. After several washes in PBST they were kept in methanol absolute. The 
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assay was carried out using the ApopTag® Peroxidase In Situ Apoptosis Detection Kit (Millipore, 
Temecula, CA) following the provided protocol: Fixed embryos were rehydrated in descending 
dilutions of methanol in H2O (75% - 50% - 25%) and washed three times in PBST for 5 minutes 
each. To quench endogenous peroxidase activity, embryos were incubated in 3% H2O2 for 10 
minutes followed by two washes in PBST for 1 minute each. Next, incubation in 100µl 
equilibration buffer for 20 minutes set the conditions for incubation in 50µl reaction solution for 1 
hour at 37°C. The process was stopped by replacing with 220µl stop/wash solution for 10 minutes 
back at room temperature. After three washes in PBST for 1 minute each, embryos were 
incubated over night in anti-DIG peroxidase conjugate at 4°C. On the next day, embryos were 
washed three times in PBST for 5 minutes each and subjected to DAB staining (see 2.5.2). 
 
2.6. Preparation of specimen and image acquisition 
2.6.1. Preparation of whole mount embryos in vivo 
For in vivo imaging using the stereomicroscope, embryos/larvae were anesthetized in 0.05% 
Tricaine (Sigma) and immobilized in 3% methylcellulose in 35 mm glass base dishes (Iwaki). The 
position relative to the objective was adjusted with a fine injection needle. For confocal imaging 
embryos/larvae were mounted in 1.5% low melting agarose (BioRad) in the same dishes.  
2.6.2. Preparation of stained whole mount embryos 
For imaging stained whole mount embryos, they were transferred into glycerol through an 
ascending gradient (33%, 66%, 100%). For imaging, embryos/larvae were mounted in 35mm 
glass base dishes (see 2.6.1). 
2.6.3. Preparation of stained flat mount embryos 
For higher resolution flat mount imaging, stained embryos were transferred into glycerol as 
described in 2.6.2. Yolk platelets were removed with fine injection needles and embryos were 
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transferred into a fresh drop of glycerol. The embryos were orientated with the needle and 
covered with a glass cover slip using separate cover slips as spacers.  
2.6.4. Manual sections 
This part was carried out by Flora Rajaei (Winkler lab; NUS). Stained embryos were transferred 
into glycerol as described in 2.5.2. With a scalpel, embryos were sliced manually in sections 
which were mounted in a fresh drop of glycerol on a microscopic slide and covered with a cover 
slip.  
2.6.5. Cryosections 
Stained embryos/larvae were embedded in 1.5% agarose/5% sucrose. Blocks containing the 
specimen were cut out and soaked overnight at 4°C in 30% sucrose. For cryosectioning on a 
CM1850 cryotome (Leica) blocks were mounted on sectioning stage with tissue freezing medium 
(Jung, Germany) and plunge frozen in liquid nitrogen. Section diameter was 20-30 µm. 
2.6.6. Plastic sections  
This part was carried out by Dr. Ann Huysseune (Ghent University, Belgium). Plastic sections of 
whole mount hybridized specimens were prepared according to Verstraeten et al. (in press). 
Briefly, whole mount embryos were slowly dehydrated through a graded series of ethanol and 
embedded in soft epon (epon A:B mixed 3:2, according to Luft, 1961). Serial transverse sections 
of 4 µm were prepared using a diamond knife mounted on a Prosan HM 360 microtome, mounted 
with DPX mountant (Sigma) and viewed under Nomarski optics on a Zeiss AxioImager Z1. 






2.6.7. Image acquisition 
Image acquisition on in vivo transgenic reporter expression was done with a Nikon SMZ1000 
stereomicroscope and a Nikon T1-SM inverted microscope with GFP filter set. Bone 
mineralization stained with ALC and osteoblasts expressing CFP were monitored with the same 
stereomicroscope with FITC and CFP filter sets. Flat mounted embryos were imaged on a Nikon 
Eclipse 90i upright microscope and NIS-element BR software (Nikon). More detailed images 
were taken on an LSM 510 Meta laser scanning confocal microscope (Zeiss). Alexa488 was 
detected by excitation with an argon multi-line gas laser at 488nm and detection through the BP 
505-530nm filter. Alexa568 was detected by excitation with a Helium Neon gas laser at 543nm 
and detection through the LP 560nm filter. CFP was detected by excitation with an argon multi-
line gas laser at 458nm and detection through the LP 475nm filter. ALC was detected by 
excitation with a Helium Neon gas laser at 543nm and detection through the LP 560nm filter.  
LSM software (Zeiss) was employed for image processing.  
2.6.7. Cell count and statistical analysis 
To eable quantitative statements about cell proliferation assays, cells were counted in the acquired 
images of multiple individuals (n). Therefore, a region of interest (ROI) was defined by framing 
the area on the images to cover the hindbrain region between rhombomeres 4 to 8. Within this 
area all positively stained nuclei were counted manually. By means of Microsoft Excel 2011 the 







3.1. Conditional ablation of osteoblasts in medaka 
3.1.1. osx-positive osteoblasts of osx:CFP-NTR transgenic medaka are sensitive towards Mtz 
treatment  
In the stable transgenic osx:CFP-NTR medaka line, a fusion protein of Nitroreductase (Ntr) and 
Cyan Fluorescent Protein (CFP) is expressed under control of the 4.2kb osx-promoter, which has 
been used previously to visualize early osteoblasts in medaka (Renn and Winkler, 2009; Fig. 3.B). 
The distinct pattern of CFP fluorescence is identical to the reporter expression of osx:mCherry 
medaka both during early and later stages (Renn and Winkler, 2009). At 20 dpf, CFP can be 
detected in all skeletal elements, such as cleithrum, operculum and pharyngeal teeth in the head, 
the fin rays of the caudal fin and in neural and hemal arches as well as the edges of the centra in 
the axial skeleton (Fig. 3.C-E).  
Fig. 3. An osx:CFP-NTR transgenic medaka line for osteoblast ablation. (A) Mechanism of 
nitroreductase (NTR) facilitated conditional cell ablation. (1) CFP and NTR (yellow cell) are 
expressed under control of the osterix promoter (blue cell). (2) Larvae are immersed in the 
prodrug Mtz (straight red bars). Only those cells that express NTR transform it into the activated 
Mtz (kinked red bars). (3) Activated Mtz is a DNA crosslinking agent that induces apoptosis. (B) 
Schematic diagram of construct used to generate the transgenic osx:CFP-NTR line. (C,D) 
osx:CFP-NTR larva at 20 dpf showing stable expression of CFP in osteoblasts (C, ventral view of 
head region; D, lateral view of entire larva). Brightfield image is combined with fluorescent 
image. Note: Blue signal in the yolk region is due to autofluorescence. (E) Higher magnification 
view of ventral body as boxed in D. Empty arrowhead demarcates anterior edge of centrum, white 
arrowhead marks posterior edge.  
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To test whether the reporter expressing osx-positive cells are sensitive towards Mtz prodrug 
treatment, osx:CFP-NTR larvae were exposed to 10mM Mtz/0.1% DMSO while the respective 
control group was incubated in 0.1% DMSO (Fig. 4B). As additional control, the same treatment 
was conducted on osx:mCherry larvae to show that the specificity of cell ablation is linked to 
NTR/Mtz interaction (Fig. 4A). At 6 dpf, larvae from both transgenic lines were dechorionated, 
incubated in Mtz and analyzed for fluorescence. At this stage osx:mCherry (Fig. 4C,D) and 
osx:CFP-NTR larvae (Fig. 4E,F) showed the typical pattern of fluorescence labeling in skeletal 
elements as described earlier (Renn and Winkler, 2009). After keeping the larvae in Mtz for 6 
days (6-12 dpf) fluorescence was analyzed again. In osx:mCherry larvae no difference between 
Mtz and DMSO treated individuals could be observed (Fig. 4G and H). In contrast, a substantial 
reduction of fluorescence signal was evident in the skeletal elements of Mtz exposed osx:CFP-
NTR larvae (Fig. 4J), whereas the DMSO treated larvae showed normal stage-specific CFP 
pattern (Fig. 4I). This effect was found to be most prominent in the cleithrum and operculum 
(arrow and arrowhead in Fig. 4J), as well as in the neural arches, whereas some fluorescence 
signal remained in the ventral craniofacial skeleton e.g. in the branchiostegal rays. Nine 
repetitions were carried out with the osx:CFP-NTR line using a total of 73 DMSO controls while 
127 larvae were exposed to Mtz. From the 60 (= 82%) surviving control larvae none showed 
reduced CFP signal while from the group of 80 (= 63%) surviving Mtz treated larvae all were 
characterized by substantial loss of fluorescence. In the four repetitions of the osx:mCherry 
control experiment, a total of 31 larvae served as DMSO controls and 48 were exposed to Mtz. 
After 6 days of treatment (dot), 30 (=97%) of the DMSO controls survived, as did 29 (=60%) of 
the Mtz treated larvae. Neither in the DMSO group nor in the Mtz group any individual was 
found with reduced fluorescent reporter signal. Taken together, these data suggest that successful 
ablation of osx-positive cells occurred only after Mtz treatment of NTR transgenic specimen. The 
regular osx-positive cell status in DMSO controls and in Mtz treated osx:mCherry larvae supports 
Mtz target specificity and excludes off target effects of the prodrug. 
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Fig. 4. Osteoblasts of transgenic osx:CFP-NTR medaka are sensitive towards treatment with 
Metronidazole (Mtz). (A,B) Schematic diagrams of constructs used in transgenic lines. (C-F) 
Larvae before onset of Mtz treatment at 6 dpf (0 dot). Note that all larvae show reporter 
fluorescence indicating the presence of osx-positive osteoblasts. (G-J) Larvae at 12 dpf after 6 
days of treatment (6 dot). Note that only osx:CFP-NTR larvae show reduction in fluorescent 
signal in skeletal structures, such as cleithrum (arrow) and operculum (arrowhead) indicating cell 
ablation. Data were obtained from 9 (osx:CFP-NTR) and 4 (osx:mCherry) independent 
experiments, representative examples are shown.  
 
3.1.2. osx-positive cells undergo apoptosis upon Mtz treatment 
Upon reduction by Ntr Mtz becomes a DNA-crosslinking agent and moderates cell ablation by 
apoptosis (Pisharath et al., 2007; Curado et al., 2008). To confirm that loss of the fluorescent 
signal is due to cell ablation, two assays for apoptotic cell death were carried out. Acridine 
Orange (AO) stains nuclei of apoptotic cells in vivo in medaka (Yasuda et al., 2008). osx:CFP-
NTR larvae which underwent Mtz treatment and their respective DMSO controls were stained 
with AO to assess occurrence and frequency of cell death. The DMSO control showed a normal 
CFP pattern (Fig. 5A,B) and no AO signal (Fig. 5E,F; n=12 embryos), which is also evident in the 
CFP/AO merged image (Fig. 5I,J). In contrast, 15 out of 17 Mtz treated larvae, which were 
characterized by substantial loss of CFP signal at the position of cleithrum, operculum and 
pharyngeal teeth (Fig. 5C,D), exhibited strong AO signal in the regions of CFP loss (see arrows in 
Fig. 5G,H). The experiment was repeated using TdT-mediated dUTP-biotin nick end labeling 
(TUNEL). While no signal could be detected in the DMSO control larvae (Fig. 5M,M’,N,N’), 
TUNEL staining was observed in 11 out of 14 Mtz treated larvae at the positions of operculum 
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and pharyngeal teeth (arrows in Fig. 5O,P, magnifies views in O’,P’) consistent with the AO 
results. Notably, these regions contain osx expressing osteoblasts (Fig. 3.D; and Renn and 
Winkler, 2009). Taken together, these findings support that loss of CFP fluorescence is a 
consequence of apoptosis due to cytotoxic properties of Ntr catalyzed reduction of Mtz in Ntr-
positive cells. 
 
Fig. 5. NTR/Mtz treatment leads to cell apoptosis as evident by Acridine Orange (A-L) and 
TUNEL assays (M-P) at 12 dpf (6 dot). (A,B) osx:CFP-NTR DMSO controls with normal pattern 
of CFP expression in skeletal elements. (C,D) Mtz treated osx:CFP-NTR larva with loss of osx-
positive cells in skeletal elements evident by loss of fluorescent signal. (E,F) Control larva shows 
no Acridine Orange (AO) signal. (G,H) Mtz treated larva with strong AO staining in regions of 
skeletal elements. (I,J) Merged images of A and E, as well as B and F, respectively. (K,L) 
Merged images of C and G, as well as D and H, respectively. (M,N) TUNEL staining reveals no 
increased apoptosis in DMSO treated control larvae (M’, N’ are higher magnification views of 
regions boxed in M and N). (O,P) Mtz treated larvae exhibit TUNEL positive cells in the 
operculum (op, arrow in O, not visible in P) and pharyngeal teeth (pt, arrow in O,P). (O’,P’) are 
higher magnification views of regions boxed in O and P. Data were obtained from two (AO) and 




3.1.3. Osteoblast loss is confirmed by osteocalcin expression analysis 
Osteocalcin (osc) is expressed in mature osteoblasts (Renn and Winkler, 2010). To verify that 
Mtz treatment leads to the loss of differentiated osteoblasts, I performed in situ hybridization with 
an osc riboprobe on Mtz treated osx:CFP-NTR larvae and their respective DMSO controls. At 12 
dpf (6 dot), the expression of osc appeared normal in DMSO control larvae (Fig. 6A,A’) while it 
was remarkably reduced in Mtz treated individuals (Fig. 6B,B’). This was even more evident at 
18 dpf (12 dot), when DMSO controls showed prominent expression in the gill regions (Fig. 
6C,C’), while osc expression was substantially reduced in 5 out of 6 Mtz treated larvae (Fig. 
6D,D’). This further supports the loss of matured osteoblasts in Mtz treated osx:CFP-NTR larvae. 
 
Fig. 6. Confirmation of osteoblast loss by osc expression analysis. Ventral view of DMSO 
controls (A/A’, C/C’) and Mtz treated larva (B/B’, D/D’) at 12 dpf (6 dot) and 18 dpf (12 dot), 
respectively. Note that Mtz treated larvae show less osteocalcin (osc) expression when compared 
to controls. A’-D’ represent higher magnification views of areas boxed in A-D. Data were 
obtained from two (12 dpf) and one (18 dpf) independent experiments, representative examples 
are shown. 
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3.1.4. Ablation of osx-positive osteoblasts results in cranial bone loss and fusion of vertebral 
centra 
To analyze the impact of osx-positive cell ablation on the skeleton, Alizarin Complexone (ALC) 
bone staining was performed in vivo on osx:CFP-NTR larvae after 12 days of Mtz treatment. In 
control larvae, the CFP signal overlaps with ALC in the head skeleton (Fig. 7A-G) and in the 
caudal fin (Fig. 7W). In the vertebral column, the neural arches show overlap of CFP and ALC 
signal (Fig. 7O-Q). CFP is also visible at the edges of the centra (arrow in Fig. 7O). This pattern 
is consistent with the spatiotemporal distribution of osx:mCherry positive cells reported by Renn 
and Winkler (2009). 
In the head skeleton, I focused my attention on analyzing two structures: the cleithrum and the 
operculum. These are among the first structures in the cranial skeleton to undergo mineralization 
and osx expression (Renn and Winkler, 2009). In control larvae at 18 dpf, osx-positive cells 
formed a layer around the mineralized cleithrum (Fig. 7A-D) and operculum (Fig. 7E-G), 
respectively, as evident by the overlap of CFP and ALC signals (Fig. 7D,G). However, in Mtz 
treated larvae, the CFP signal was substantially reduced. No osx-positive cells could be detected 
around the cleithrum (Fig. 7H-K) and only few cells remained to cover the operculum (Fig. 7L-
N). Furthermore, the cleithrum and operculum showed weaker mineralization compared to 
controls (Fig. 7C,J and Fig. 7F,M) and the operculum exhibited large furrow shaped structures 
devoid of any obvious mineralization (Fig. 7M).  
In the axial skeleton of controls, osx-positive cells are positioned around the neural arches and at 
the borders of each chordal centrum next to the base of the arches (Fig. 7O-Q). The intervertebral 
region is located between the centra (arrowheads in Fig. 7P). In Mtz treated larvae, CFP 
expression was absent (Fig. 7R-T). Mineralization of the neural arches was reduced (compare Fig. 
7P,S), and the arches appeared disorganized when compared to controls (arrow in Fig. 7S). Also, 
no CFP expression could be detected around the centra which indicates that all osx-positive cells 
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also in this region were ablated (Fig. 7R). Interestingly, the size of the intervertebral regions 
(compare arrowheads in Fig. 7P and S) was strongly reduced and the chordal centra appeared 
partially fused. Such fusions occurred at various positions along the vertebral column (see Fig. 
7W for different larva). ALC staining displayed an over-mineralization in the centra of Mtz 
treated larvae concomitant with a substantial loss of CFP signal (Fig. 7W,X) compared to their 
DMSO controls (Fig. 7U,V). Mineralization was extended across the rostrocaudal borders of 
several centra resulting in a fusion of vertebral bodies. This phenotype was observed in 34% (11 
of 32) of analyzed larvae which showed centra fusions at various regions along the vertebral 
column after 12-16 dot (see Fig. 8 for additional examples). Such over-ossification phenotypes 
were only observed in Mtz treated osx:CFP-NTR larvae but neither in DMSO controls (n=58) nor 
in osx:mCherry transgenic larvae (n=29, DMSO treated; n=16, Mtz treated) or wild type larvae 
(n=23, DMSO treated; n=17, Mtz treated). This suggests that the phenotype is a direct 
consequence of NTR/Mtz mediated osx-positive cell ablation.  
Taken together, these data suggest that depletion of osx-positive osteoblasts reduces ossification 
of early bone structures, such as the cleithrum, operculum and neural arches. Interestingly 
however, it also leads to over-mineralization in the vertebral column and fusion of centra in a 
proportion of NTR/Mtz treated embryos. This suggests that osx-positive cells possibly have a 
border defining function in the developing vertebral column, required for the metameric 
appearance of the vertebral bodies. 
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Fig. 7. Ablation of osx-positive osteoblasts leads to defective ossification in head and axial 
skeleton. (A-N) Lateral views of head region of DMSO control (A-G) and Mtz treated larva (H-
N). B-D and I-K are higher magnification views of cleithrum boxed in A and H, respectively. 
Operculum of a DMSO control (E-G) and Mtz treated larva (L-N). Note: Loss of CFP and 
absence of mineralization in cleithrum and operculum of Mtz treated larvae when compared to 
controls. (O-T). Views on anterior centra in DMSO controls (O-Q) and Mtz treated larvae (R-T). 
Arrow in O points at CFP positive cells in rostral area of centra. Arrowheads in P and S indicate 
intervertebral regions. Arrow in S points at disorganized neural arch. Note loss of CFP and fusion 
of anterior centra in Mtz treated larva. (Q,T) Merged images of O/P and R/S, respectively. (U-X) 
Lateral views on DMSO control (U,V) and Mtz treated larvae (W,X). Note fusion of centra in 
Mtz treated larva (arrowheads in X compared to V). U and W images were taken with a 
stereomicroscope, all others with a confocal microscope. V and X are projections of confocal z-
stacks, all others are single stack images. All pictures were taken at 18 dpf (12 dot) with anterior 
to the left. Data were obtained from nine (osx:CFP-NTR), four (osx:Mcherry) and four (wild-




Fig. 8. Additional examples of Mtz treated osx:CFP-NTR larvae exhibiting fused centra at 18 dpf 
(12 dot). (A,B) DMSO treated control larva and Mtz treated larva, respectively, stained with 
Alizarin Red. The cleithrum of Mtz treated larva shows reduced mineralization (A’,B’). The 
vertebral column shows fusion of centra at various positions (arrowheads in B). A’/A’’ and B’/B’’ 
are higher magnifications of regions boxed in A and B. (C,C’) Additional example of Mtz treated 
larvae stained with ALC showing ectopic mineralization in several vertebral bodies (arrowheads). 
(D,D’) Same larva as shown in C/C’ exhibiting over-mineralization under brightfield illumination 
(arrowheads). A’-D’ are magnifications of frames in A-D. All pictures were taken in lateral view 
with anterior to the left. Data were obtained from nine independent experiments, representative 
examples are shown. 
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3.1.5. osx-positive tissue regenerates after Mtz treatment  
Next, I addressed whether ablated osx-positive cells can be replenished after Mtz treatment to 
regenerate bone tissue. osx:CFP-NTR larvae were subjected to Mtz treatment from 6 dpf to 15 dpf 
(9 days) to ablate osx-positive cells (Fig. 9A). Compared to DMSO controls (Fig. 9B/B’), Mtz 
treated larvae showed severe reduction of osx-positive cell numbers as evident by reduced CFP 
fluorescence (Fig. 9C/C’). Subsequently, the Mtz solution was removed, larvae were washed 
several times in Danieau’s solution and allowed to recover for 10 more days until 25 dpf. For this, 
single larvae were kept separated to allow tracking of individual recovery situations. The status of 
osteoblast regeneration was assessed at day 20 (5 days post treatment; dpt) and day 25 (10 dpt). 
At 5 dpt, I observed an increase of CFP fluorescence in all 11 Mtz treated larvae (Fig. 
9C/C’,E/E’). Compared to controls at the identical stage, however, there was still less CFP signal 
in these larvae (Fig. 9D/D’,E/E’). At 10 dpt, over 50% of the Mtz treated larvae showed almost 
identical CFP signal intensity when compared to controls at 5 dpt (Fig. 9D/D’,G/G’). Notably, the 
size of the operculum after 10 days of regeneration was comparable to controls at 15 dpf 
(compare Fig. 9G’ to B’). Taken together, these data suggest that medaka larvae are able to 
compensate for the loss of osteoblasts by regeneration in this cell lineage.  
 52 
Fig. 9. Regeneration of ablated osx:CFP-NTR cells. (A) Schematic view of experimental timeline. 
osx:CFP-NTR larvae were incubated in Mtz for the indicated period (6 dpf-15 dpf). Subsequently, 
larvae were allowed to recover for 10days. Images were taken at time points indicated (15/20/25 
dpf). DMSO controls (B) and Mtz treated larva after treatment (C). Arrows in B’ indicate 
cleithrum (cl) and operculum (op). (D-G) CFP expression in controls (D, F) and Mtz treated larva 
(E, G) after 5 and 10 days recovery, respectively. Note increasing CFP in Mtz treated larvae 
during recovery. A’-G’ show high magnification views of areas boxed in A-G, respectively. All 
pictures were taken in lateral view with anterior to the left. Data were obtained from three 







3.2. Functional characterization of Lrp5 and its putative inhibitor Sost during craniofacial 
skeleton formation 
3.2.1. Lrp5 and Sost are conserved at the sequence level 
Sequence information for zebrafish lrp5 and sost is available in the Ensembl database 
(www.ensembl.org). lrp5 is located on chromosome 25 and annotated as 
ENSDARG00000006921. It spans a genomic region of over 140 kilobases (kb) (10,854,422- 
10,981,755), with an open reading frame (orf) of 4845 basepairs (bp) in 24 exons. The deduced 
amino acid (aa) sequence contains 1615 aa. Using ClustalW multiple alignment 
(www.ebi.ac.uk/Tools/msa/clustalw2; Chenna et al., 2003) the protein sequence was compared to 
orthologs in human (HsLrp5; ENSG00000162337), mouse (MmLrp5; ENSMUSG00000024913), 
Xenopus (XtLrp5; ENSXETG00000010024) and fruitfly (DmArrow; FBgn0000119). 
Pairwise alignments generated with bl2seq (http://blast.ncbi.nlm.nih.gov; Altschul et al., 1997) 
revealed sequence identities of 76% with HsLrp5, 75% with MmLrp5, 76% with XtLrp5 and 43% 
with DmArrow, respectively. A zebrafish sost ortholog annotated as ENSDARG00000061259 
was identified on chromosome 12, spanning a 4kb region (28,902,441-28,906,682). The size of 
the orf is 630bp in two exons and the deduced protein consists of 210 aa. The protein alignment of 
zebrafish Sost (DrSost) with orthologs in human (HsSost; ENSG00000167941), mouse 
(MmSOST; ENSMUSG00000001494), chicken (GgSost; ENSGALG00000009929) and Xenopus 
(XtSostdc1; ENSXETG00000022798) showed an overall conservation of Sost (Fig. 10B), which 
is lower than for Lrp5. However, eight cysteine residues relevant for the tertiary cys-knot 
structure of Sost (Weidauer et al., 2009) are highly conserved in all species analyzed (Fig. 10B; 
and data not shown). Pairwise alignments revealed sequence identities of 54% with HsSost, 49% 
with MmSost, 59% with GgSost and 45% with XtSostdc1, respectively. Taken together, both lrp5 
and sost genes are conserved during vertebrate evolution, with an lrp5 ortholog existing in 
invertebrates (arrow, in Drosophila).  
 54 
 
Fig. 10. Lrp5 and Sost are conserved at the sequence level. Alignment of Lrp5 and Sost amino 
acid sequences. (A) Schematic illustration of predicted Lrp5 protein domains (top). Numbers 
indicate amino acid positions and refer to human Lrp5. Grey boxes represent signal peptide (1-32) 
and transmembrane domain (TM), respectively. β-1 to β-4 indicate β-propeller domains 1 to 4. 
The β-1 domain is proposed to bind to Sost. Bottom: Alignment of amino acid sequences in the β-
1 domain. Glycine at position 171, which is mutated to valine in human patients with high bone 
mass phenotypes (Boyden et al., 2002) is highlighted in grey. (B) Amino acid alignment of Sost 
proteins. Cysteine residues at conserved positions are highlighted in grey. 
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3.2.2. Complementary and overlapping expression of Lrp5 and its putative inhibitor Sost 
during cranial skeleton development in zebrafish 
3.2.2.1. Early expression of zebrafish lrp5 and sost 
In situ hybridization with antisense probes targeting lrp5 and sost mRNA indicated that both 
genes are maternally expressed in zebrafish. At the 8-cell stage, strong staining was observed for 
lrp5 (Fig. 11A) and sost (Fig. 11F). During late epiboly/bud stage and 10 somite stage (ss/14 hpf) 
lrp5 is ubiquitously expressed (Fig. 11B,C). Around 20 ss, the ubiquitous lrp5 expression gets 
restricted and becomes concentrated in the CNS (arrowhead in Fig. 11D; Fig. 11E) and tail region 
(arrow in Fig. 11D). In contrast, zygotic sost is not expressed during epiboly stages (Fig. 11G). 
Earliest embryonic sost expression can be detected around 10 ss as two bilateral patches in the 
posterior head region (arrows in Fig. 11H,I). Subsequently, the pattern is complemented by a 
medial stripe along the hindbrain that is observed at 25 ss (black arrowheads in Fig. 11J,K; Fig. 
11L). At this stage, the lateral stripes fused at the ventral side of the head (white arrowhead in Fig. 
11J,K) and sost expression can also be seen in ventral mesoderm cells posterior to the yolk 
extension (arrow in Fig. 11J,K). To illustrate the dynamics of the sost expression pattern in the 
hindbrain during these stages, a series of flat-mount preparations was analyzed between 10 and 25 
ss (Fig. 11Mi-vi). I observed that during successive stages (indicated by body axis growth; Fig. 
11Mi-vi, top), the medial expression intensifies (Fig. 11Mi-iii) and divides into two bilateral 
domains (Fig. 11Miv), which gradually move into distal directions to surround the hindbrain 




Fig. 11. Early embryonic expression of lrp5 and sost. (A-D) Lateral views of embryos showing 
lrp5 expression at 8-cell stage (A), bud-stage (B), 10 somite stage (ss) (C), 25 ss (D; arrowhead 
indicates hindbrain expression, arrow indicates tailbud expression).  (E) Flat mounted embryo at 
25 ss. (F-K) Whole mount embryos showing sost expression at 8-cell stage (F), bud-stage (G), 10 
ss lateral (H) and dorsal (I), 25 ss lateral (J) and frontal (K; black arrowhead indicates hindbrain 
expression; white arrowhead indicates bilateral ventral expression; arrow indicates ventral 
mesenchyme). (L) Flat mounted embryo at 25 ss. (Mi-Mvi) Emerging hindbrain expression of 
sost between 12 and 25 ss as whole mounts (top) and flat mounts (bottom). Anterior is to the left 
in B,C,D,G,H,J,M (top) and to the top in E,I,L,M (bottom). 
 
 
3.2.2.2. Expression of lrp5 and sost at 24 and 48 hpf 
At 24 hpf, expression of lrp5 is found in the cranial region and in the trunk preferentially in the 
brain and in the neural tube (Fig. 12A). In the trunk, only weak expression can be detected in the 
mesoderm and no transcripts are detectable in the notochord and the finfold ectoderm (Fig. 12A’). 
In the head however, highest levels of expression are found in the hindbrain (Fig. 12B), whereas 
lower expression is also seen in the diencephalon and the mid-hindbrain boundary region, except 
in the dorsal-most regions (Fig. 12A). No obvious expression is found in the tectum and 
telencephalon (Fig. 12A).  
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Sost expression is evident in a well defined row of cells that lines the hindbrain ventricle dorsally 
and also in the ventral head region (Fig. 12C). In the trunk, sost is expressed ventral to the 
notochord, with increased levels in the ventral mesenchyme caudal to the yolk extension (Fig. 
12C’). The pattern of sost expression around the hindbrain ventricle is limited anteriorly by the 
rhombic lip (Fig. 12D). Intermediate levels of expression are found throughout the entire CNS 
(Fig. 12C). In the ventral head region, sost is expressed in the pharyngeal arch region where 
postmigratory neural crest cells are located (Fig. 12C,D’). 
At 48 hpf, strong lrp5 expression persists in the head region and weaker expression is observed in 
the trunk (Fig. 12E). Also the pectoral fin buds show lrp5 expression (arrows in Fig. 12E). Lrp5 is 
found broadly expressed in the dorsal neural tube (Fig. 12F, arrow) and ventral to the notochord 
(arrowhead in Fig. 12F). Broad expression is found throughout the head with elevated levels in 
the dorsal hindbrain (Fig. 12G,H) and in the diencephalon (arrow in Fig. 12G). In contrast, 
expression is weak or absent in the tectum and telencephalon. lrp5 is also strongly expressed in 
the presumptive ventral mesenchyme (arrowhead in Fig. 12G; Fig. 12G’). The lrp5 expression 
pattern in the hindbrain was next analyzed in transverse sections. The cells generating the bilateral 
domains are positioned in the dorsal-most layer of the hindbrain (Fig. 12H,I) and join at its 
posterior end (Fig. 12H,J). In both sections, also lrp5 positive cells in the pharyngeal arches are 
visible (arrowheads in Fig. 12I,J).  
sost expression at the same stage is more restricted and most prominent in the head region (Fig. 
12K). Expression of sost is also found in a segmental pattern in the trunk (arrowhead in Fig. 12L). 
Cross-sections revealed that sost expressing cells are flanking the neural tube in regions where 
neural arches develop in later stages (arrowheads in Fig. 12L’). The sost expressing cells are also 
visible in the pharyngeal arches in the anterior section (arrowhead in Fig. 12M and Fig. 12M’). 
The border-like pattern around the hindbrain persists (Fig. 12M,N). Unlike the broad expression 
of lrp5 in this region, sost is expressed only in a subset of cells in these lrp5 domains (compare 
Fig. 12H to N). Transverse sections show that the sost positive cells are also positioned at the 
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dorsal-most edges of the hindbrain (Fig. 12N,O) and that these domains like for lrp5 join at the 
posterior end of the hindbrain (Fig. 12N,P). Notably, in both structures, hindbrain and pharyngeal 
arches, lrp5 and sost are co-expressed. However, lrp5 shows a broader expression while sost is 
confined to a few cells within the cluster of lrp5 positive sells.  
 
 
Fig. 12. lrp5 and sost expression at 24 and 48 hpf. (A) Lateral view of lrp5 expression seen in 
whole mount embryo at 24 hpf. (A’) Higher magnification view of trunk region. (B) Dorsal view 
of head. (C) Lateral view of sost expression at 24 hpf. (C’) Trunk region at higher magnification. 
(D) Dorsal view of head. (D’) Inset showing plane of focus on post-migratory neural crest 
streams. (E-H) Whole mount embryos showing lrp5 expression at 48 hpf (E; arrow points to 
pectoral fin bud). (F) Lateral view of trunk at higher magnification (arrow indicates expression in 
dorsal neural tube; arrowhead points to ventral expression). (G) Lateral view of head (arrow 
indicates epiphysis; arrowhead pharyngeal arch region; inset in G’ shows ventral view of 
pharyngeal arch region). (H)  Dorsal view of head showing broad distribution of lrp5 transcripts. 
(I,J) Transverse plastic sections at levels indicated in E, arrowheads point to pharyngeal arches; 
scalebar in I = 50 µm. (K-N) sost expression in whole mount embryos. (L) Higher magnification 
of trunk. Inset in (L’) shows cryosection at position indicated in K (arrowheads mark sost 
expression adjacent to ventral neural tube). M. lateral view of head (arrowhead indicates sost 
expression in presumptive ventral head mesenchyme; inset in M’ shows ventral view of 
pharyngeal arch region). (N) Dorsal view of head. (O,P) Transverse plastic sections at levels 
indicated in K, arrowhead in O points to sost expression in pharyngeal arches. Anterior is to the 
left in all whole mount pictures. 
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3.2.2.3. Expression of lrp5 and sost at posthatching stages 
At 72 hpf, both lrp5 and sost expressions become more restricted to distinct domains. Lrp5 is 
strongly expressed in the head (Fig. 13A,B) as well as the pectoral fins (arrows in Fig. 13B). In 
the head, expression is found prominently in the dorsal hindbrain (white arrowhead in Fig. 13C; 
arrow D) including the rhombic lip, as well as in the epiphysis (arrow in Fig. 13C). No expression 
is evident in the tectum and telencephalon. Strong expression is also found throughout the 
forming pharyngeal skeleton in the ventral head region (black arrowhead in Fig. 13C; Fig. 13C’). 
Transverse sections show the broad expression of lrp5 in this region (arrowhead in Fig. 13D). 
Sections through the hindbrain highlight that this expression persists but appears fainter than at 48 
hpf (compare Fig. 13E,F to Fig. 12I,J). The same sections also reveal strong expression of lrp5 in 
the pectoral fin (arrowhead in Fig. 13F).  
At the same stage, sost is no longer expressed in the hindbrain and its expression is limited to the 
ventral head region (Fig. 13G,H) and the pectoral fin (arrows in Fig. 13H). In contrast to the 
broad lrp5 expression, sost expression is confined to cartilaginous cranial neural crest cell 
(CNCC) derivatives. At this stage, the morphogenesis of the ventral cranial skeleton has advanced 
and single elements are distinguishable as they distinctively express sost. Meckel’s cartilage 
(arrow in Fig. 13I), ceratohyal (white arrowhead in Fig. 13I,I’) and the distal parts of 
ceratobranchials (black arrowhead in Fig. 13I,I’) are visible. Transverse sections at the level of 
the ceratobranchials show that sost expression is confined to the innermost cartilaginous cells 
(arrowhead in Fig. 13J). At this stage, sost expression is also found in cartilaginous structures 
dorsal to the mouth cavity i.e. the palate (arrow in Fig. 13J) More caudal sections confirm that 
expression in the hindbrain has vanished (Fig. 13K,L,).  
At 7 dpf, expression of lrp5 is found exclusively in the head (Fig. 13M,N). Expression in the 
dorsal hindbrain persists but has changed its pattern along with the hindbrain morphology. It is 
visible in the rhombic lip (white arrowhead in Fig. 13O) and epiphysis (arrow in Fig. 13C). 
Furthermore, broad lrp5 expression can be found in all structures of the ventral cranial skeleton 
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(arrowhead in Fig. 13O; Fig. 13O’) and the ethmoid plate (asterisk in Fig. 13O). Sagittal (Fig. 
13P) and transverse (Fig. 13R) sections through the ceratobranchials show expression of lrp5 
throughout the extensions of these structures (cartilage of the gill filaments). It is not overlaying 
with cartilaginous elements that directly derive from NCCs as evident by comparison with a DAB 
stained sox10:GFP larva in the same stage (Fig. 13Q). Expression is also evident throughout the 
pectoral fins and concentrated in a basal line, presumably the scapulocoracoid (Fig. 13S).  
Sost expression at this stage is confined to the ventral cranial skeleton in a much more restricted 
pattern than lrp5 (Fig. 13T,U). Expression is absent in the hindbrain (Fig. 13V) but strong in parts 
of Meckel’s cartilage (arrow in Fig. 13V) as well as in the ceratobranchials (arrowhead in Fig. 
13V; Fig. 13V’). Sagittal (Fig. 13W) and transverse (Fig. 13X) sections show that sost expression 
is confined to cells within the distal tips of the gill filaments comparable to lrp5 (compare Fig. 
13W to P). However, sost expression is excluded from the surrounding epithelial cells. In the 
pectoral fins, sost expression is limited to the endochondral disc (Fig. 13Y). 
 
Taken together, the spatiotemporal expression ananlysis of lrp5 and sost suggest that both genes 
functionally interact also in zebrafish as has been shown in mammals. However, in zebrafish, the 
embryonic expression patterns in the brain, ventral head mesenchyme and its derivatives suggest 
that their function might also be required for mechanisms in early cranial morphogenesis, other 
than in mammals where both factors have been implicated in bone homeostasis. Interestingly, the 
spatial correlation of the expression patterns seems to follow a general principle: lrp5 is expressed 
in broader domains while its putative inhibitor sost is confined to smaller domains overlapping 
with lrp5 expression.  
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Fig. 13. Expression of lrp5 and sost at 72 hpf and 7 dpf. (A-C) lrp5 expression in whole mount 
embryos at 72 hpf; lateral view in A, dorsal view in B (arrows point to pectoral fin buds), higher 
magnification lateral view of head in C (arrow points to epiphysis; white arrowhead to mid-
hindbrain boundary and black arrowhead to jaw). (C’) Ventral view of pharyngeal arch region. 
(D-F) Transverse plastic sections at levels indicated in B (arrow in D points at rhombic lip; 
arrowhead on ventral mesenchyme; arrowhead in F indicates pectoral fin bud; scalebar in D = 50 
µm). (G-I) sost expression in whole mount embryos at 72 hpf (arrows in H point to pectoral fin 
buds). (I) Lateral view of head (arrow indicates Meckel’s cartilage; white arrowhead ceratohyal; 
black arrowhead ceratobranchials). I’. Higher magnification ventral view of pharyngeal arch 
region (arrowheads as in I). (J-L) Transverse plastic sections at levels indicated in H (arrowhead 
in J points on forming ceratobranchial; arrow on palate). (M-S) lrp5 expression at 7 dpf. (M) 
Lateral view. (N) Ventral view. (O) Lateral view of head at higher magnification (asterisk 
indicates ethmoid plate; arrow points to epiphysis; white arrowhead to mid-hindbrain boundary 
and black arrowhead to gills). Inset (O’) shows higher magnification view of ventral head region. 
(P,Q) Sagittal cryosections through pharyngeal arch region showing lrp5 expression (P; scalebar 
= 10 µm), and GFP immunostaining in neural crest derived cartilage in a sox10:GFP-larva (Q). 
(R) Transverse plastic section at level of ceratobranchials showing lrp5 expression; scalebar = 20 
µm. (S) Flat mounted pectoral fin. (T-Y) sost expression at 7 dpf in lateral (T) and ventral view 
(U), and as higher magnification view of head (V; arrow shows Meckel’s cartilage; arrowhead 
points to pharyngeal arches; V’ magnification of ventral head region). Cryo sagittal (W) and 





3.2.3. sost but not lrp5 expression is controlled by FGF signaling 
In order to test whether lrp5 or sost expression is regulated by FGF, embryos were treated with 
the FGF inhibitor SU5402 (Mohammadi et al., 1997) for 3 hours between the 14 and 20 ss. 
Subsequently, larvae were fixed and subjected to in situ hybridization to check for alterations in 
the expression patterns of lrp5 and sost. No changes in the lrp5 expression pattern could be 
observed in SU5402 treated embryos (Fig. 14B; n = 26) compared to DMSO controls (Fig. 14A; n 
= 24). However, for sost expression significant differences were observed. 100% of DMSO 
treated embryos (n = 69) showed wild-type expression of sost (Fig. 14C,E-G), while 94% of 
SU5402 treated embryos (n = 82) showed a substantial reduction of the ventral sost domain 
(compare asterisks in Fig. 14D,H to arrows in Fig. 14C,E), whereas the dorsal stripe remained 
unaffected in most cases (compare arrowheads in Fig. 14C,E to Fig. 14D,H). Detailed views of 
the hindbrain (compare Fig. 14F,I) show no alteration while close-ups of the ventral part 
(compare Fig. 14G,J) indicate the loss of ventral sost expression upon SU5402 treatment.  
 
Taken together, these experiments suggest that sost expression but not lrp5 expression is 
controlled by Fgf signaling. This is particularly intersting, since Fgf signaling has been shown to 
be one of the key players in craniofacial morphogenesis (Crump et al., 2004; Hall et al., 2006; 
Walshe and Mason, 2003). Furthermore, these data suggest a novel link between Wnt and Fgf 
signaling in this process. Thus, the presented results will allow further insight into the complex 




Fig. 14. sost but not lrp5 expression is dependent on Fgf signaling. (A,B) lrp5 expression in 
whole mount embryos at 20 ss. DMSO control (A) and SU5402 treated embryo (B). Note that 
controls and treated individuals show no difference in lrp5 expression. (C-J) sost expression in 
embryos at 20 ss. Lateral (C,D) and frontal (E,H) views of whole mount preparations. F,I,G,J 
show higher magnification dorsal views with focal plane on dorsal (F,I) and ventral (G,J) sost 
expression domains in head. C,E-G. DMSO treated control embryos. D,H-J. SU5402 treated 
embryos. Note reduced sost expression in ventral but not dorsal domains in SU5402 treated 
embryo. Data were obtained from three independent experiments, representative examples are 
shown. 
 
3.2.4.  lrp5 gene knock-down leads to defects in hindbrain and CNCCs 
To analyze the role of lrp5 during zebrafish embryogenesis, I carried out a Morpholino 
oligonucleotide (Mo) knock-down approach. Different combinations and concentrations of Mos 
targeting the splice donor site of the 2nd intron (lrp5MoUp) as well as the splice acceptor site 
(lrp5MoDown, Fig. 16A) were tested for efficacy. All used Mo combinations resulted in distinct 
phenotypes (Fig. 16H,I; see page 65 for detailed explanation) in a concentration dependent 
manner (Fig. 15; Table 2). The most efficient approach was a combination of lrp5MoUp and 
lrp5MoDown both in a concentration of 0.3 mM as it resulted in the highest ratio of classI 
defective embryos (Fig. 15). This setting was used for all experiments described below and 
henceforth addressed as lrp5Mo. Individual injection of lrp5MoUp as well as lrp5MoDown also 
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resulted in a similar phenotype (Fig. 15 column 4,5,7,8; Table 2). This is further proof arguing in 
favor of the specificity of the knock-down as the probability for the same off-target effects caused 
by two independent Morpholinos is low. As an additional control, a mismatch Mo with five base 
replacements to the original sequence of lrp5MoUp was designed (lrp5MoUpMM). Injection of 
lrp5MoUpMM did not lead to any obvious morphological defects (Fig. 15 column 6; Table 2).  
 
 
Fig. 15. Knock-down of lrp5 is dependent on morpholino dose. Graphical interpretation of 
statistics of lrp5Mo injections. For definition of classI and classII defects see page 65 and Fig. 
16H,I. For exact numbers see table 2 in appendix on page 95. 
 
To determine efficiency of the Mo mediated knock-down, I used RT-PCR for semi-quantitative 
analysis of transcript levels (Fig 16B).  Choosing a primer combination (primer up + primer 
down2 in Fig. 16A) to amplify a region of cDNA that covers Exon2 and Exon3 revealed reduced 
levels of correctly spliced lrp5 cDNA in the morphant (lane 3 in Fig. 16B) compared to wild-type 
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(lane 1 in Fig. 16B) and control morphant (mmMo; lane 2 in Fig. 16B). Moreover, a second 
weaker band at slightly higher position became visible in the morphant lane, suggesting an 
alternatively spliced product. Additionally, the same cDNAs were tested for quantities of 
unspliced transcripts using the primer combination primer up and primer down1 (Fig. 16A). In 
this case, the amount of PCR product was substantially higher in the morphant situation (lane 6 in 
Fig. 16B) compared to wild-type (lane 4 in Fig. 1B) and mismatch Mo (lane 5 in Fig. 16B). No 
changes were seen between the levels of β-actin cDNA in the different entities (lane 7-9 in Fig. 
16B). 
Consistent with the expression of lrp5 in the hindbrain (see 3.2.1; 3.2.2), I found this organ 
severely affected in lrp5 morphant embryos at 48 hpf. Compared to the wild-type control (Fig. 
16C), lrp5 morphants were characterized by widely inflated hindbrain ventricles (Fig. 16D).   
CNCCs are known to originate in the dorsal hindbrain and form substantial parts of the cranial 
skeleton. Hence, I checked for the morphology of the ventral cranial skeleton structures at 
advanced larval stages by bone/cartilage staining. While the wild-type (Fig. 16F) and mismatch 
morphant skeletons (Fig. 16G) appeared normally developed (compare to schematic illustration in 
Fig. 16E), lrp5 morphants exhibited severe malformations (Fig. 16H,I). I distinguished between 
two classes of severity (see injection statistics in Table 2 and Fig. 15). ClassI morphants were 
characterized by complete loss of ceratobranchials 1-4 (arrowhead in Fig. 16H) and a reverse 
oriented ceratohyal. The 5th ceratobranchials with attached pharyngeal teeth was still present 
(arrow in Fig. 16H). In the more affected classII morphants, only rudiments of the ventral 
craniofacial skeletal structures such as Meckel’s cartilage or ceratohyal remained while the 1st till 
5th ceratobranchials were completely missing (arrowhead in Fig. 16I).  
Recent reports about unspecific apoptosis in the course of Mo mediated knock-down experiments 
(Robu et al., 2007) raised the necessity to assess possible off-target effects in the lrp5 knock-
down situation. It has been shown that unspecific apoptosis is mainly mediated by the cell cycle 
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master regulator p53 and consequently knock-down by p53Mo can reduce or rescue this effect. 
To ensure that the lrp5 loss-of-function phenotype is specific, I also checked for the structure of 
the cranial skeleton after compound knock-down of lrp5 and p53. As evident by cartilage 
staining, the same defects can be seen (Fig. 16J) in a comparable statistical distribution as occurs 
upon normal lrp5Mo injection (Table 2 and Fig. 15; row/column 3). Thus, the observed lrp5 
morphant phenotype is specific and not caused by off-target defects due to Morpholino injection. 
A more detailed analysis was undertaken using toluidine blue stained cross sections through wild-
type and classI morphant larvae (Fig. 16K-N) at 5 dpf. Wild-type larvae showed well 
differentiated cartilaginous arches at this stage (Fig. 16K). In the morphant situation, however, 
although pharyngeal cartilages are present and well differentiated in some areas, their number, 
shape and position seems to be aberrant and hence their identification is difficult, with exception 
of the hyosymplectic (Fig. 16L). In terms of dentition, cross sections interestingly showed no 
malformations in these structures in the morphants. According to the classification by Huysseune 
et el. (1998) wild-type larvae at 5 dpf (Fig. 16M) have 3V1, 4V1 and 5V1 tooth structures on each 
side, with 4V1 attached and possessing a replacement tooth, 4V2, in early cytodifferentiation. 
Teeth 3V1 and 5V1 are in a similar stage at late cytodifferentiation, and do not have a replacement 
tooth, yet. In lrp5 morphants (Fig. 16N), the same three teeth are present: 3V1, 4V1 and 5V1. 
Individuals with tooth 4V1 in late cytodifferentiation have teeth 3V1 and 5V1in morphogenesis 
stage; individuals with tooth 4V1 still in early cytodifferentiation stage have teeth 3V1 and 5V1 in 
initiation stage only. Tooth 4V1 displays no replacement tooth, but this is not to be expected given 
that a replacement tooth develops only once its predecessor is attached, which is not yet the case. 
Thus, analyzing the tooth organization revealed that not all ventral head structures are generally 
affected in the lrp5 morphants. Rather, while tooth development was apparently normal, the 
cartilage elements of the head skeleton, which are CNCC derived, were strongly affected. This 
opens the possibility that Lrp5 is solely required for morphogenesis of CNCC derived craniofacial 
structures.  
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Fig. 16. Knock-down of lrp5 leads to defects in the craniofacial skeleton, but not the teeth. (A) 
Schematic representation of the lrp5 transcript and the chosen Mo knock-down strategy. (B) RT-
PCR on mRNA isolated from morphant embryos, +/- indicates presence or absence of RT 
enzyme. For use of primercombinations see 3.2.5.3 (C,D) Morphology of wild-type vs. lrp5 
morphant embryo at 48 hpf. Note the inflated hindbrain in morphant. (E) schematic illustration of 
viscerocranial skeleton. (F-J) Combined bone and cartilage staining at 7 dpf of wild-type (F), 
lrp5MM morphant (G), lrp5 morphant classI (H), classII (I) and lrp5/p53 compound morphant 
(J). Note that morphants show absence of ceratobranchials (arrowheads) while 5th ceratobranchial 
and pharyngeal teeth (arrow) are present in classI morphants. (K-N) cross sections through 5 dpf 
larvae. Wild-type (K) shows clear distribution of ceratobranchials which is lost in lrp5 morphant 
(L). More posterior sections show that both, wild-type (M) and lrp5 morphants (N) have normal 
establishment of pharyngeal teeth (arrows). Anterior is to the left in C-J.  
 
 
3.2.5. Knock-down of lrp5 reduces canonical Wnt signaling activity 
According to the proposed function of Lrp5 as a Wnt co-receptor I tested whether reduction of 
functional Lrp5 would lead to reduced intensity of Wnt signal transduction. TOPdGFP transgenic 
zebrafish carry a construct expressing destabilized GFP under control of a Lef1/β-catenin 
responsive promoter (Dorsky et al., 2002). Hence, this line is used as a tool to measure activity of 
canonical Wnt signal transduction. At around 20 ss, all observed transgenic embryos (n=33) 
showed strong reporter activity in the midbrain-hindbrain boundary (MHB) region, as well as in 
the hindbrain and the presomitic mesoderm (PSM) in the tailbud as seen by in situ hybridization 
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using antisense riboprobes against gfp transcripts (Fig. 17A,B; see also Dorsky et al., 2002). In 
lrp5 morphants, however, 80% (n=51) showed decreased GFP expression in all body parts (Fig. 
17C,D), suggesting substantial down regulation of Wnt activity.  
To confirm this finding and to specify that Wnt signaling is reduced in neural crest cells, I also 
examined transcript levels of lymphoid enhancer-binding factor 1 (lef1), a key downstream player 
in Wnt signal transduction (MacDonald et al., 2009), thus being a suitable indicator of Wnt 
signaling activity. Importantly, at around 20 ss it is expressed in migratory CNCCs as well as in 
the tailbud (Fig. 17E). The CNCC expression appears in two bilateral stripes adjacent to the 
hindbrain (Fig. 17F) as reported earlier (Dorsky et al., 1999). 73% (n=80) of lrp5Mo injected 
embryos showed a substantial reduction in lef1 expression in all expression domains (Fig. 17G). 
Especially in the CNCCs lef1 expression was strongly reduced (Fig. 17H).   
 
Fig. 17. Knock-down of lrp5 reduces canonical Wnt signaling activity. (A-D) TOPdGFP embryos 
at around 20 ss stained for gfp transcripts. (A,B) Uninjected control, (C,D) lrp5 morphant. Note 
that gfp expression is downregulated in morphant. (E-H) 20 ss embryos stained for lef1 
transcripts. (E,F) Wild-type embryo, (G,H) lrp5 morphant. Note that lef1 expression is 
downregulated in morphant, especially in CNCC regions (see asterisk in G and arrows in F,H). 
Anterior is to the left in all pictures.  
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3.2.6. Lrp5 knock-down does not affect induction of CNCCs 
Wnt signaling has been shown to play multiple roles in neural crest induction, migration and 
differentiation (Lewis et al., 2003). In order to examine, whether Lrp5 is important for neural 
crest induction, I checked for alterations in expression of the early CNCC marker gene forkhead 
box d3 (foxd3; Kelsh et al., 2000).  At 10 ss, premigratory CNCCs express foxd3 and are found 
bilaterally to as well as overlying the neuroepithelium at a more caudal part of the hindbrain (Fig. 
18A,B). No difference in the expression level or pattern of foxd3 was observed in lrp5 morphant 
embryos (100%, n=28; Fig. 18C,D) compared to the respective wild-type controls (n=32; Fig. 
18A,B), indicating that Lrp5 is not involved in early CNCC induction.  
 
3.2.7. Knock-down of lrp5 affects CNCC migration 
Next, I wanted to analyze whether the migratory behavior and pattern of CNCCs is altered by 
knock-down of lrp5. At around 14-15 hpf CNCCs start migrating in three distinct streams lateral 
to rhombomeres 2, 4 and 6 from dorsal to ventral towards the pharyngeal arch region. At around 
20 ss, cells in these streams can be identified by their expression of distal-less homeobox 2a 
(dlx2a; Fig. 18E-I; Akimenko et al., 1994) while no expression can be seen in the 
neuroepithelium (arrow in Fig. 18G and cross-section I). Knock-down of lrp5 drastically changed 
the pattern of migratory CNCCs, as streams appeared substantially reduced and disorganized in 
45% of morphant embryos (n=64; Fig. 18J,K). Importantly, a patch of dlx2a positive cells 
appeared ectopically on top of the neuroepithelium as evident in cross sections, between the 
branchial stream of migratory CNCCs at rhombomere 6 (Fig. 18 asterisk in J; K; arrow in L and 
asterisk in cross-section N). This stream furthermore appeared severely reduced in size (Fig. 
18M) compared to wild-type control (Fig. 18H). No changes in the dlx2a expression pattern could 
be found in lrp5MoUpMM morphants (n=59; Fig. 24E,F). This experiment suggests that 
migration of CNCCs in the branchial stream seems to be disturbed by loss of Lrp5 function.  
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To confirm this finding, migratory CNCCs were also examined by staining for the pan-neural 
crest marker crestin (Luo et al., 2001). In wild-type embryos crestin is expressed in cranial and 
trunk neural crest cells (Fig. 18O). Around 20 ss no stained cells could be seen on top of the 
neuroepithelium (arrow in Fig. 18Q) but in the two bilateral streams of migratory NCCs (Fig. 
18P,Q,R and cross section S). In 55% (n=64) of the lrp5 morphant embryos, however, the crestin 
expression pattern shows a comparable defect as observed by dlx2a staining:  Clusters of crestin 
positive NCCs are located on top of the neuroepithelium (arrow in Fig. 18V; asterisk in cross 
section X) whereas the branchial clusters of crestin positive migratory CNCCs appear 
substantially reduced in size and cell number (Fig. 18W) compared to the wild-type situation (Fig. 
18R). No changes in the crestin expression pattern could be found in lrp5MoUpMM morphants 
(n=54; Fig. 24G,H). 
The effect of lrp5 knock-down on migratory CNCCs was further confirmed by similar results 
obtained in in vivo experiments using lrp5 morphants in a sox10:GFP transgenic background 
(Dutton et al., 2008). In this transgenic line, cells of the neural crest lineage are detectable by 
reporter expression positioned in the migratory streams around 20 ss, while no cells are found in 
the dorsal hindbrain region (arrow in Fig. 18Y). In contrast, 54% of lrp5Mo injected embryos 
(n=74) showed clusters of ectopic GFP positive cells on the neuroepithelium (arrow in Fig. 18Z) 
comparable to the results obtained by staining for dlx2a/crestin transcripts. Accordingly, the 
caudal clusters of migratory CNCCs are of smaller size than in the wild-type controls.  
Taken together, all three observations indicate that a knock-down of lrp5 results in alterations of 
the migratory behavior of CNCCs, while their induction is not affected. Although the observed 
ectopic cells have some migratory CNCC character as evident by dlx2a expression, not all of 
them join and follow the migratory streams but seem to be retained in the dorsal neuroepithelium 




Fig. 18. lrp5 morphants display normal induction but defective migration of CNCCs. (A-D) 
Embryos at 10 ss stained for foxd3 transcripts. (A,B) Wild-type embryo, (C,D) lrp5 morphant. 
Note that no alteration in foxd3 expression can be seen. (E-N) Embryos at 20 ss stained for dlx2a 
transcripts. (E-I) Wild-type embryo, (J-N) lrp5 morphant. Note that ectopic dlx2a expression is 
present at the dorsal neuroepithelium of rhombomere 6 in lrp5 morphants (asterisk in J,N; arrow 
in L) and the streams of branchial migratory CNCCs are reduced in size (M).  (O-X) Embryos at 
20 ss stained for crestin transcripts. (O-S) Wild-type embryo, (T-X) lrp5 morphant. Note that 
ectopic crestin expression is present at the dorsal neuroepithelium of rhombomere 6 in lrp5 
morphants (asterisk in T,X; arrow in V) and the streams of branchial migratory CNCCs are 
reduced in cell number (M).  (Y,Z) Confocal projections of sox10:GFP embryos at 20ss showing 
reporter expression in CNCCs. (Y) Uninjected control embryo, (Z) lrp5 morphant. Note that 
ectopic GFP+ cells are present at the dorsal neuroepithelium of rhombomere 6 in lrp5 morphants 
(arrow) and the streams of branchial migratory CNCCs are reduced in cell number. Anterior is to 
the left in all pictures, except cross section. Magnifications in G,H,L,M,Q,R,V,W are indicated by 





3.2.8. Proliferation of premigratory CNCCs is affected by knock-down of lrp5 
From the previous findings it was not conclusive if knock-down of lrp5 only affected the 
migratory behavior of CNCCs or also their total number. Premigratory NCCs are highly 
proliferative and canonical Wnt signaling has been shown to control the NCC cell cycle (Burstyn-
Cohen et al., 2004). Furthermore, it has been reported that avian NCC delamination is tightly 
synchronized with the cell cycle (Burstyn Cohen and Kalcheim, 2002). I assessed the proliferative 
status of neuroepithelium cells in rhombomeres 4 to 8 in lrp5 morphant embryos at 20 ss by 
immunohistochemical staining for phosphorylated Histone 3 (pH3), which is a marker for M-
phase nuclei (Fig. 19A,A’,B,B’). In lrp5 morphant embryos the number of positively stained 
nuclei was reduced by an average of 37% compared to wild-type controls (P<10-6; n=11) in the 
respective region of interest (roi; Fig. 19C).   
To get a better picture about the situation of cells in the DNA synthesis (S) phase of the cell cycle 
I checked for Bromodeoxyuridine (BrdU) incorporation in lrp5 morphants at the same 
developmental stage. As it had been reported in chicken, NCCs synchronize in S-phase for 
delamination from the neuroepithelium (Burstyn Cohen and Kalcheim, 2002), thus being a 
prerequisite for the migratory process. In lrp5 morphants, I found significantly less cells staining 
positive for incorporated BrdU (Fig. 19D,D’,E,E’). In the area between rhombomere 4-8, I 
determined a 36% reduction of S-phase nuclei (P=1.05x10-6; n=11; Fig. 19F).  
In order to further examine which phase of the cell cycle is affected by lrp5 knock-down I 
checked for cyclin d1 (ccnd1) transcript levels. ccnd1 is expressed in G1 phase and is responsible 
for G1/S-transition. It has been shown to be expressed under transcriptional control of Wnt 
signaling (Tetsu and McCormick, 1999), also in the zebrafish neural crest (Berndt and Halloran, 
2006).  Surprisingly, ccnd1 was substantially up-regulated in the hindbrains of 68% (n=22) of 
lrp5 morphant embryos (Fig. 19G-J). Despite a possible conflict with previous reports, this 




Fig. 19.  Proliferation of premigratory CNCCs is affected by knock-down of lrp5. (A,B) 20 ss 
embryos stained for pH3+ cells in M-phase. (A) Wild-type embryo, (B) lrp5 morphant. Frames 
demarcate area of cell count (roi, region of interest) and are magnified in (A’,B’) to examplify 
counting mode (cells indicated by asterisks). Note that in the lrp5 morphant pH3+ cells are 
reduced in number. (C) Quantification of pH3+ cell numbers in the neuroepithelium of 
rhombomeres 4-6. n=9/11 (wild-type/lrp5 morphant). *P<10-6, t-test. (D,E) 20 ss embryos stained 
for BrdU incorporation. (D) Wild-type embryo, (E) lrp5 morphant. Frames demarcate area of cell 
count (roi) and are magnified in (D’,E’) to examplify counting mode (cells indicated by 
asterisks). Note that in the lrp5 morphant BrdU+ cells are reduced in number. (F) Quantification 
of BrdU+ cell numbers in one unilateral neuroepithelium of rhombomeres 4-6. n=9/11 (wild-
type/lrp5 morphant). *P=1.05x10-6, t-test. (G-J) 20 ss embryos stained for ccnd1 transcripts. 
(G,H)  Wild-type embryo, (I,J) lrp5 morphant. Note that ccnd1 is enhanced in lrp5 morphants.  
Frames in G,H indicate magnified area in flatmount H,J. Anterior is to the left in all pictures. 
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arrest in hindbrain cells of lrp5 morphants as evident by accumulation of ccnd1. Consequently, 
this would lead to the reduction of S-phase cells, which is exactly what was seen in the lrp5 
morphants (Fig. 19E). 
 
3.2.9. Absence of postmigratory CNCCs due to lrp5 knock-down results in cranial skeleton 
malformation 
The head skeleton emerges from derivatives of the cranial neural crest. It was expected that the 
observed failure of CNCC proliferation and migration (see 2.4 and Fig. 3) would result in reduced 
numbers of postmigratory cells in the pouches of the pharyngeal arches. To test this hypothesis, I 
examined lrp5 morphants in the fli1:EGFP transgenic background (Lawson and Weinstein et al., 
2002). This transgenic line shows reporter expression under control of the friend leukemia 
inhibitor1-promoter, expressed in vascular endothelial cells as well as in CNCC derivatives. Thus, 
at around 30 hpf the mandibular (md), the hyoid (hy) and the three branchial (br) patches of 
postmigratory CNCCs can be identified in the lateral head region of wild-type embryos (Fig. 
20A,A’). In contrast, in 65% of lrp5Mo injected embryos (n=32), these structures were absent or 
strongly reduced (Fig. 20B,B’). I followed the affected embryos during further development and 
analyzed morphogenesis and positions of GFP positive CNCC derivatives. At 48 hpf, the 
pharyngeal arches in the uninjected control were well established as visible by the five clearly 
distinguishable columns of GFP positive cells (Fig. 20C,C’) oriented bilaterally in the caudal head 
region (Fig. 20E,E’). In contrast, the lrp5 morphants failed to establish proper pharyngeal arch 
morphology. Only a group of disorganized GFP+ cells at the posterior end could possibly be 
identified as 5th branchial arch (ba5?; Fig. 20D,D’,F,F’).   By 72 hpf, the morphogenetic processes 
have directed the gross of neural crest derivatives to their morphogenetic destinations so that the 
GFP-positive cells resemble the main architecture of the mature ventral cranial skeleton and 
structures like Meckel’s cartilage (mc), the ceratohyal (ch) and the five ceratobranchials (cb) are  
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Fig. 20. Absence of postmigratory CNCCs due to lrp5 knock-down results in cranial skeleton 
malformation. (A-B’) fli1:EGFP transgenic embryos at 30 hpf. (A,A’) Uninjected control embryo, 
(B,B’) lrp5 morphant. Note that the mandibular (md), hyoid (hy) and three branchial (br) patches 
of postmigratory CNCCs are well defined in wild-type but missing in lrp5 morphants. (C-F’) 
fli1:EGFP transgenic ambryos at 48 hpf. (C,C’) Uninjected control embryo lateral view, (D,D’) 
lrp5 morphant lateral view, (E,E’) uninjected control embryo dorsal view (F,F’) lrp5 morphant 
dorsal view. Note that metameric morphology of pharyngeal arches is absent in lrp5 morphant. 
Only the 5th branchial arch seems to be present (ba5?). (G-J’) fli1:EGFP transgenic ambryos at 72 
hpf. (G,G’) Uninjected control embryo lateral view, (H,H’) lrp5 morphant lateral view, (I,I’) 
uninjected control embryo dorsal view (J,J’) lrp5 morphant dorsal view. Note that in wild-type 
skeletal elements like Meckel’s Cartilage (mc), ceratohyal (ch) and 1st till 5th ceratobranchials (cb 
1-5) can be distinguished at this stage, whereas in lrp5 morphant only the mc and ch are 
recognized while the cbs are undefined. Anterior is to the left in all images. Boxed areas in X are 
magnified in X’.  
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distinguishable (Fig. 20G,G’,I,I’; compare to Fig. 1H). In the lrp5 morphants, however, the 
absence of pharyngeal arches leads to severe malformation in the morphology of the cranial 
skeleton. Some rudiments of the caudal pharyngeal arches are visible in the lateral view (Fig. 
20H,H’). While most parts of the anterior skeleton such as Meckel’s cartilage (mc) are visible in 
the ventral view (Fig. 20J,J’) only rudiments of the ceratohyal can be identified (ch) and the 
morphology of the ceratobranchials (cb) is hardly established.  Taken together these data illustrate 
how the morphogenetic process from postmigratory NCCs to distinct structures of the cranial 
skeleton takes place in the course of development and how initial absence of postmigratory 
CNCCs in lrp5 morphants leads to the morphological defects that are detectable by cartilage 
staining, eventually.  
 
3.2.10. Knock-down of sost phenocopies knock-down of lrp5 
Zebrafish sost, encoding a putative inhibitor of Lrp5 in Wnt signaling, is expressed at the critical 
stages of CNCC migration (around 20 ss) in the posterior hindbrain neuroepithelium (see Fig. 11) 
and in neural crest derivatives at later stages of development (Fig. 12 and Fig. 13). For a targeted 
gene knock-down approach to inhibit functional Sost, I designed a set of splice site Mos. Several 
concentrations of combined Mos targeting the splice donor (sostMoUp) and splice acceptor 
(sostMoDown) sites of the only intron in the sost gene were tested for efficiency. All experiments 
resulted in distinct phenotypes in a concentration dependent manner (Fig. 21; Fig. 22B; Table 3). 
The best results in terms of ratios of specifically affected embryos in morphant batches were seen 
by combined injection of 0.15mM sostMoUp and sostMoDown. This concentration was used for 
all experiments and is henceforth addressed as sostMo. A mismatch Mo with five random 
nucleotide replacements was used as additional control and did not result in any defects 
(sostMoUpMM; see Fig. 21, column 5; Table 3). sostMo injection specifically prevented correct 
splicing of sost pre-mRNA as evident by reduced amounts of PCR product using an intron 
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spanning primer pair on cDNA of injected embryos compared to wild-type (compare lane 4 to 
lane 3 in Fig. 22A). β-catenin was used as a control to ensure same cDNA concentration in the 
compared entities (see lane 1 and 2 in Fig. 22A).  
 
Fig. 21. Knock-down of sost is dependent on morpholino dose. Graphical interpretation of 
statistics of sostMo injections. For definition of classI and classII defects see page 65 and Fig. 
16H,I; Fig. 22B. For exact numbers see table 3 in appendix on page 95. 
 
 
sostMo injection resulted in severe malformations of the ventral cranial skeleton comparable to 
the situation after knock-down of lrp5 (Fig. 16). Cartilage staining at 7 dpf revealed a complete 
absence of ceratobranchials in morphant larvae (Fig. 22B, arrowhead) and a reduced and reversed 
ceratohyal. Rudiments of the 5th ceratobranchials are visible (Fig. 22B, arrow). 
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Next, I wanted to check whether the observed craniofacial defects result from comparable defects 
as seen in the lrp5 morphant situation. For this, I assessed the proliferative status of 
neuroepithelial cells in rhombomeres 4 to 6 in sost morphant embryos at 20 ss by 
immunohistochemical staining for pH3+ nuclei (Fig. 22C,D). In sost morphant embryos the 
number of positively stained nuclei was reduced by an average of 36% compared to wild-type 
controls (P<10-6; n=11) in the respective area (Fig. 22E).   
Accordingly, I analyzed gene expression patterns of the migratory CNCC marker dlx2a and the 
pan-neural crest marker crestin.  The same defective distribution of CNCCs was found in sost 
morphants as earlier observed for lrp5 morphants. In 20% of morphants (n=82), NCCs positive 
for dlx2a were found partially retained in the dorsal hindbrain and reduced in number especially 
in the caudal migratory streams of CNCCs compared to wild-type and mismatch controls (Fig. 
22F-I; Fig. 24I,J; n=65). The same situation was observed by staining for crestin positive cells in 
24% of the morphants (n=75; Fig. 22J-M). No alterations in the crestin expression pattern was 
found in sostMoUpMM morphants (n=47; Fig. 24K,L).  
In line with these findings, fli1:EGFP positive postmigratory CNCCs were substantially reduced 
in number at around 30 hpf in 54% of sost morphant embryos (compare morphants in Fig. 22O 
with wild-type in N). Accordingly, at 3 dpf, when the CNCC derivatives demarcate the 
architecture of the ventral craniofacial skeleton in the wild-type (Fig. 22P) the number of 
fli1:EGFP positive cells in sost morphants was substantially reduced especially in the caudal part 
(Fig. 22Q).  
Taken together, these data suggest that knock-down of sost results in morphological defects that 
are very similar to those obtained after knock-down of lrp5.   
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Fig. 22. Knock-down of sost phenocopies knock-down of lrp5. (A) RT-PCR with mRNA from 
wild-type (wt) and sost morphants (mo). (B) Cartilage staining of 7 dpf sost morphant larva. 
(C,D) 20 ss embryos stained for pH3+ mitotic cells. (C) Wild-type embryo, (D) sost morphant. 
Note that in the sost morphant pH3+ cells are reduced in number. (E) Quantification of pH3+ cell 
numbers in the neuroepithelium of rhombomeres 4-6. n=9/11 (wild-type/lrp5 morphant). *P<10-6, 
t-test. (F-I) Embryos at 20 ss stained for dlx2a transcripts. (F,G) Wild-type embryo, (H,I) sost 
morphant. Note that ectopic dlx2a expression is present at the dorsal neuroepithelium of 
rhombomere 6 in sost morphants (asterisk in H; arrow in I’) and the streams of branchial 
migratory CNCCs are reduced in cell number (I’’).  (J-M) Embryos at 20 ss stained for crestin 
transcripts. (J,K) wild-type embryo, (L,M) sost morphant. Note that ectopic crestin expression is 
present at the dorsal neuroepithelium of rhombomere 6 in sost morphants (asterisk in L; arrow in 
M’) and the streams of branchial migratory CNCCs are reduced in cell number (T). (N-Q)  
fli1:EGFP embryos showing reporter expression in postmigratory CNCCs and their derivatives. 
(N) Uninjected control embryo at 30 hpf, (O) sost morphant at 30 hpf. Note that postmigratory 
CNCCs are missing in sost morphant. (P) Uninjected control at 72 hpf, (Q) sost morphant at 72 
hpf. Note that ceratobranchials are absent in sost morphant. X’ and X’’ are magnifications of 











4.1 Conditional cell ablation in medaka 
To gain new insights into the role of osteoblasts in development of the vertebral column, I 
generated the osx:CFP-NTR transgenic line. This approch enabled conditional ablation of the 
osteoblast cell lineage which was evident by reduced reporter and marker gene expression as well 
as enhanced apoptosis in skeletal elements and resulted in reduced mineralization of cranial bone 
structures and vetrebral spines. In contrast, vertebral bodies were found fused, which suggests a 
new and additional function of osteoblasts in defining vertebral borders. Additionally, 
regenerative properties of osteoblasts could be seen by gradual reappearance of reporter 
expression after withdrawal of drug treatment.  
This study shows for the first time the successful application of the NTR/Mtz cell ablation system 
in medaka. In the past, this system has been used to enable tissue specific cell ablation in mouse 
cell cultures (Bridgewater et al., 1995) with CB1954 as prodrug and also in zebrafish. In this 
model successful ablation of heart muscle cells, β-cells, liver cells, retinal cells, testicular cells 
and epidermal cells has been carried out  (Pisharath et al., 2007; Curado et al., 2008, Zhao et al., 
2009; Hsu et al., 2009; Chen et al., 2011). To efficiently ablate osteoblasts in our osx:CFP-NTR 
medaka model, where the NTR is expressed under control of the osteoblast specific osx promoter, 
I had to modify previously described protocols. In my experiments, only homozygous individuals 
showed efficient cell ablation, while heterozygous did not (data not shown) indicating the 
requirement of a critical threshold of NTR. In previous reports using transgenic zebrafish 
expressing tissue specific NTR, substantial cell ablation has been detected after 24 hours exposure 
to 10 mM Mtz (Pisharath et al., 2007; Curado et al., 2008). For an efficient ablation of osteoblasts 
in osx:CFP-NTR medaka, however, larvae needed to be exposed to 10 mM Mtz for at least 6 
days. We hypothesize that it takes a higher dose of Mtz to reach the osteoblasts that are generally 
surrounded by dense extracellular matrix. In addition, also higher levels of NTR-metabolized Mtz 
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might be needed to exert any toxic effect on osteoblasts. Unfortunately, a detailed study testing 
the effect of Mtz on different cell types is lacking, but we assume that osteoblasts might be more 
resilient than e.g. liver cells as described before. After 6 dot, cell ablation was only observed in 
skeletal elements that showed CFP-NTR expression already at the start of treatment, namely the 
cleithrum and operculum. Here, cells metabolized Mtz throughout the entire incubation period, 
which eventually resulted in ablation. In contrast, CFP at 6 dot was also observed in elements 
which contain cells with a later onset of endogenous osx expression, i.e. the hyosymplectic, the 
quadrate or the branchiostegal rays (Renn and Winkler, 2009). In these bones, Mtz was only 
metabolized for shorter periods due to the later onset of osx-promoter driven CFP-NTR 
expression suggesting that accumulation of the cytotoxic drug might not have reached toxic levels 
in the analyzed time window.  
The frequently observed death of osx:CFP-NTR and osx:mCherry/wild-type control larvae after 
long time Mtz exposure suggests that also non-processed Mtz has some unspecific toxic effects. 
In addition, survival rates of Mtz exposed osx:CFP-NTR larvae (25%) were lower than those of 
osx:mCherry (33%) and wild-type larvae (53%) suggesting off target toxicity also of Ntr 
metabolized Mtz during long time exposure. Consistently, increase of Mtz concentration to 20 
mM resulted in even lower survival rates (data not shown). Increase of temperature to 37°C, on 
the other hand, did not enhance NTR/Mtz specific cell ablation, as expected from earlier reports 
(Emptage et al., 2009). The reasons for the different observations made in medaka and zebrafish 
studies are not clear but might be due to species and/or tissue-specific differences and/or different 
promoter efficiencies. All successful NTR approaches in zebrafish published so far report 
efficient cell ablation within 24 h of exposure, suggesting that the resilience might be due to 
species specific features, rather than a particular tissue.  
Using Acridine Orange and TUNEL assays, we could show that the loss of osteoblasts is due to 
apoptosis. This is in line with previous reports on the mode of NTR/Mtz facilitated cell ablation 
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(Pisharath et al., 2007; Curado et al., 2008). However, due to the rather slow cell ablation process 
apoptosis was only detectable in areas of highest osteoblast density, such as the operculum and 
the pharyngeal teeth. Onset of osc expression occurs later than osx in the process of osteoblast 
maturation. osc is expressed in mature osteoblasts (Renn and Winkler, 2010) and secreted into the 
extracellular bone matrix (Hauschka et al., 1989). We could show that osc transcription is reduced 
in Mtr treated larvae confirming cell ablation of mature and ossifying osteoblasts.  
The impact of osteoblast ablation on bone mineralization was assessed by live skeletal staining 
with ALC in Mtz treated osx:CFP-NTR larvae. The cleithrum and operculum as cranial bones 
showed reduction of mineralization suggesting a discontinued deposition of extracellular bone 
matrix after ablation of the majority of osteoblasts in these elements. The remaining mineralized 
structures are probably deposits made by osteoblasts before the Ntr/Mtz driven ablation occurred 
or from remaining osteoblasts not targeted by Mtz. In neural arches, osteoblast ablation also 
resulted in reduced mineralization. These arches were characterized by irregular shapes possibly 
due to mechanical effects exerted from tissue growing around the mineralized arches. 
Surprisingly, a fusion of centra and excess mineralization was observed in 32% of individuals 
treated with Mtz for 12-16 days. We speculate that this fusion is caused by the ablation of 
osteoblasts positioned at the edges of the rostro-caudally extending chordal centra. This might 
result in the aberrant outgrowth and fusion of centra at the expense of intervertebral regions. 
Studies in zebrafish and Atlantic salmon have proposed a direct role for notochord cells in 
mineralizing the notochordal sheath, the innermost layer of the centra (Fleming et al., 2004; 
Grotmol et al., 2005). Hence, it remains to be tested whether notochord cells, upon ablation of 
osteoblasts at the edges of the extending centra, become activated to produce excess mineralized 
notochordal sheath. Alternatively, it has been reported that sclerotome derived osteoblasts are 
situated around the notochordal sheath and secrete minerals to form the perichordal centrum and 
extend this structure in rostrocaudal direction (Inohaya et al., 2007). Interestingly, Spoorendonk 
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and colleagues (2008) suggested the presence of osx-negative osteoblasts to be implicated in this 
process. This opens the possibility that osx-negative osteoblasts could be responsible for the 
centra fusion observed after ablation of osx-positive cells. Unfortunately, however, such osx-
negative osteoblasts remain speculative and still await identification and characterization. Our lab 
has recently identified a novel marker that labels these proposed osx-negative osteoblasts (J. 
Renn, personal communication) therefore providing further support for my model. Importantly, 
how a metameric pattern is generated in the teleost vertebral column still remains unclear. We 
show that osx-positive cells first appear at the anterior and posterior edges of each centrum and 
that their ablation leads to fusion of the centra. Therefore, it is possible that the presence of these 
osteoblasts is necessary to prevent outgrowth of the centra into the intervertebral space. Hence, 
osx-positive cells could have a function in defining the borders of the forming centra thus 
contributing to the segmental pattern of the vertebral column.  
We could show that the osteoblast lineage is capable of regenerating after Ntr/Mtz induced cell 
ablation. In all observed larvae, the CFP signal gradually reappeared in skeletal elements after 
previous cell ablation. Therefore, we assume that this lineage actively compensates for the severe 
loss of osteoblasts. However, further studies are required to clarify the underlying mechanisms 
and the origin of newly formed osteoblasts. The field of regeneration biology has recognized the 
potential of fish as model for heart (Poss, 2007), liver (Sadler et al., 2007) or appendage 
regeneration (Iovine, 2007; Knopf et al., 2011). In the future, studying osteoblast regeneration in 
medaka via osx:CFP-NTR can help to gain a better understanding of the processes involved in 
maintaining the equilibrium between osteoblasts and osteoclasts as well as osteoblast reactivation 
and growth. These mechanisms are vital for bone homeostasis and often disturbed in human bone 
diseases. Thus, this could eventually lead to new therapeutic strategies to counteract osteoporosis 
in human patients as well as enhance regeneration of bone mass in the process of fracture healing.  
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4.2. Overlapping expression of Lrp5 and its putative inhibitor Sost during cranial skeleton 
development in zebrafish 
Next, I sought to study aspects of craniofacial skeleton morphogenesis, in particular its molecular 
control by Wnt signaling. Thereofore, I focused on Lrp5 in zebrafish. Knock-down of these 
factors seemed a better approach for modulation of Wnt signal transduction than targeting one or 
several of the 15 different Wnt ligands and 11 Fz receptors in zebrafish. Furthermore, I was 
interested in studying the role of Sost in zebrafish, which has been described as an inhibitory 
factor of Wnt signaling in more recent vertebrates and is suggested to exert its function through 
binding to Lrp5. 
The tight spatiotemporal correlation of lrp5 and sost expression suggests a possible functional 
interaction in zebrafish as has been described in mammalian bone metabolism. In contrast to the 
situation in mammals, however, restricted expression of both genes was found in distinct regions 
of the brain and ventral cranial skeleton during early and late stages of embryogenesis. In general, 
we find that in zebrafish lrp5 is expressed in broader domains while its putative inhibitor sost is 
confined to more restricted domains overlapping with or directly adjacent to  lrp5 expression.  
In mammals, a detailed embryonic expression of lrp5 and sost has never been assessed. However, 
the distinct bone associated phenotypes in knock-out mice and human patients suggested a role of 
the two genes in osteoblasts, and an additional function of Lrp5 in eye vascularisation (Gong et 
al., 2001; Kato et al., 2002).  
Head cartilage formation in zebrafish has been reported to be dependent on FGF signaling, 
however a link between Fgf and Wnt signaling in this process had so far not been established 
(Crump et al., 2004; Hall et al., 2006; Walshe and Mason, 2003). The results from my SU5402 
mediated Fgf inhibition experiments clearly suggest that sost expression is controlled by Fgf 
signaling. I observed that down-regulation of sost was limited to the ventral expression domain in 
the developing embryo around 20 ss. Interestingly, we noticed that expression of pea3, which 
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encodes an ETS-domain transcription factor mediator of Fgf signaling (Besser et al., 1995), 
overlaps with this ventral sost expression in 20ss embryos (Munchberg et al., 1999) but not with 
the emerging hindbrain expression which remains unaffected. This suggests that Fgf control over 
sost transcriptional activity could be mediated through Pea3. 
Crosstalk between Fgf and Wnt signaling is important throughout many aspects of embryonic 
development (reviewed by Dailey et al., 2005). To explain the underlying mechanisms how both 
pathways are integrated, previous models have been focusing on the intracellular components of 
the two pathways. Our observation of Fgf control of sost transcription therefore adds a novel 
aspect to this cross-talk as it involves an extracellular factor in the interaction between Fgf and 
Wnt signaling.  
Mammalian cell culture experiments have shown that Sost expression is positively regulated by 
bone morphogenetic proteins (BMPs), retinoic acid and vitamin D or abolished by dexamethasone 
(Winkler et al., 2003; Ohyama et al., 2004; Sutherland et al., 2004). Moreover, Sost expression is 
directly suppressed by parathyroid hormone (PTH), both in vitro and in vivo, via PTH receptor 
type 1 (PTH1R; Keller and Kneissel, 2005). Two master regulators of osteoblast differentiation, 
Runx2 and Osterix, have been analyzed for their role in regulating sost expression. Sost appears 
to be a component of the Runx2 autoregulatory circuit (Sevetson et al., 2004). Suppression of 
Osterix mRNA by small interfering RNA (siRNA) resulted in down-regulation of SOST mRNA 
expression in primary osteoblast cells suggesting a positive role for Osterix in SOST regulation 
(Ohyama et al., 2004). With our data obtained in vivo in zebrafish, we present FGF signaling as a 
possible novel upstream regulator of sost expression.  
 
4.3. A role for Lrp5 and Sost in morphogenesis of the craniofacial skeleton in zebrafish 
The results presented in this thesis suggest a novel role for Lrp5 and Sost in early patterning 
events during vertebrate embryogenesis.  
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In zebrafish with knock-down of  Lrp5 as well as Sost I observed the strongest defects during 
craniofacial development occurring in ceratobranchials 1-4, while the 5th ceratobranchial and the 
pharyngeal teeth appear unaffected at least in classI morphants. This was also evident by the 
pattern of sox10:GFP positive cells in 7 dpf larvae (not shown). Only few GFP+ cells are present 
in the 5th ceratobranchials demonstrating that this structure is mostly of non-CNCC origin. This 
explains why this element is not affected by loss of Lrp5 function. The pharyngeal teeth are a 
product of the pharyngeal epithelium posterior of ceratobranchials 5 (Huysseune et al., 1998) and 
no sox10:GFP+ cells can be found in this region. Consequently, the dentition in lrp5 morphants 
looks normal: teeth are in the correct position, they display proper alignment relative to each 
other, and appear in the exact order, as judged from their developmental stage. The dentition 
appears to be slightly delayed with respect to wild-type, and corresponds to the dentition of 
specimens aged between 56 and 72 hpf.  Taken together, the absence of ceratobranchials 1-4 with 
the 5th one and dentition being unaffected shows that the effect of the morphant phenotype is 
limited to CNCC derivatives in the ventral cranial skeleton.  
We were able to show that the observed skeletal defects result from events that take place earlier 
in development. Wnt signaling is known to be involved in different steps of NCC development, 
including induction as it has also been shown in zebrafish (Lewis et al., 2004). However, although 
lrp5 is expressed in the areas of NCC induction at the corresponding stages, it seems not to be 
involved in the process, as the number and pattern of premigratory CNCCs was not affected in the 
morphant situation. This is particularly interesting, since in Xenopus miss-expression of a 
truncated dominant-negative variant of Lrp6 leads to reduced NCC induction (Tamai et al., 2000). 
Importantly, sost is not yet expressed at the developmental stage of NCC induction.  In both 
morphants, however, I observed aberrant localization of migratory CNCCs in embryos at 
advanced stages. Around 20 ss, when CNCCs have already evaded from the neuroepithelium in 
wild-type embryos, cells of the branchial stream were found left behind in the dorsal part of 
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rhombomere 6 (see model in Fig. 23A). These cells were unambiguously identified as NCCs as 
they were positive for the marker genes crestin, sox10 and dlx2a. Interestingly, dlx2a is only 
expressed in migratory CNCCs. This finding suggests that these cells in the morphants had 
already undergone EMT but failed to pursue migration towards the pouches of the pharyngeal 
arches. Canonical Wnt signaling has been shown to be indispensable for NCC migration in vitro 
(de Melker et al., 2004). In zebrafish, it has been shown that Wnt signaling is linked to N-
cadherin by Ovo1 and thereby regulates NCC migration (Piloto and Schilling, 2010). Wnts are 
also activators of snail, which is a repressor of E-cadherin (Vallin et al., 2001). Thus, the 
observation that CNCC migration is disturbed in lrp5/sost morphant zebrafish embryos adds an 
additional aspect to the understanding how cell migration in the cranial neural crest is regulated 
by Wnts.  
As it has been shown in chick embryos, delamination of NCCs is tightly intertwined with their 
cell cycle and synchronized in S-phase. Moreover, this process has been shown to be mediated by 
Wnt signals (Burstyn-Cohen et al., 2004). In lrp5 and sost morphants, the cell cycle of 
premigratory CNCCs appears arrested, as I found reduced numbers of nuclei in M-phase and S-
phase in the relevant rhombomeres, where CNCCs originate. This suggests involvement of 
Lrp5/Sost also in cell cycle control of premigratory CNCCs. Such a role for Wnt signaling had 
been suggested earlier by Berndt and Halloran (2006). They showed comparable phenotypes by 
employing heatshock driven expression of dominant-negative TCF to inhibit Wnt signal 
transduction. In this study, they also reported reduced numbers of S-phase nuclei in premigratory 
CNCCs. However, which Wnt components were responsible for this defect remained unknown.  
Wnt signals regulate the cell cycle directly through transcriptional control over ccnd1 and thereby 
control G1/S-phase transition (Tetsu and McCormick, 1999). This mechanism has been shown to 
also apply to the zebrafish neural crest (Berndt and Halloran, 2006). However, I found that in the 
lrp5 morphants, the transcriptional level of ccnd1 was substantially increased. One possible 
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explanation for this surprising finding could be that Lrp5 mediated Wnt signaling might exert 
additional effects on the cell cycle that are dysfunctional in the knock-down situation. Thus, 
elevated levels of ccnd1 transcripts in parallel with reduced BrdU incorporation could be 
interpreted as a sign of blocked G1/S-phase transition. Possibly, these arrested cells could keep 
feeding back on the ccnd1 promoter so that transcripts accumulate due to lack of checkpoint 
signals. Interestingly and supporting this idea, a comparable situation has been described in serum 
deprived mouse osteoblast cell cultures, in which RNAi mediated downregulation of LEF1 also 
resulted in the upregulation of Cyclin D1 (Galindo et al., 2007). 
Noteworthy, migrational defects such as observed in my experiments are not necessarily a direct 
consequence of reduced proliferation of premigratory CNCCs and impaired S-phase 
synchronization. Knock-down of Semaphorin3D in zebrafish was shown to result in reduced 
proliferation of premigratory CNCCs (Berndt and Halloran, 2006). As a consequence migratory 
CNCCs were found reduced in number yet importantly did not show loss of migratory behavior. 
This suggests that migratory properties of CNCCs are not directly linked to preceding 
proliferation and delamination, and that the migration defects observed in my experiments can 
also be explained by an additional migratory function of Lrp5.  
Taken together, Lrp5/Sost mediated Wnt signaling might be essential for multiple steps in this 
process, i.e. proliferation of premigratory CNCCs and therefore S-phase synchronized EMT as 
well as subsequent migration of delaminated CNCCs (Fig. 23B). This model is in line with the 
fact that Wnt signaling has been shown to play multiple roles in the different phases of NCC 
development (Lewis et al., 2004). Furthermore, the finding that Lrp5 and Sost are involved in 
proliferation but not in specification of CNCCs is comparable to the reported function of mouse 
Lrp5, which is responsible for proliferation of osteoblasts but not for their differentiation (Kato et 
al. 2002). Similar but yet unknown intracellular mechanisms could possibly be involved.  
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Fig. 23. Schematic interpretation of proposed model. (A) Comparison between wild-type (WT) 
and Lrp5/Sost loss-of-function situation. Whereas in wild-type cells migrate,  in lrp5/sost 
morphants they are trapped dorsally. (B) Wnt signaling is known to be involved in all steps of 
NCC development. Nevertheless, induction of NCCs (orange cells) seems to work independent of 
Lrp5/Sost. Proliferation and migration seems directly dependent of Lrp5/Sost mediated Wnt 
signaling, and EMT could indirectly depend on Lrp5/Sost mediated cell cycle control. 
 
Sost is known to be an inhibitory factor of canonical Wnt signaling. Its loss-of-function should 
therefore result in reduced inhibition of Wnt signal transduction in contrast to down-regulation by 
loss of Lrp5 function. Most surprisingly, the phenotypes obtained after sost knock-down showed 
appealing similarities with the described lrp5 morphant phenotypes. I therefore suggest that Sost 
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exerts its function through binding to Lrp5 in zebrafish similar to what has been described in 
mouse (Ellies et al., 2006; Li et al., 2005; Semenov et al., 2005). Additionally, we suggest that 
zebrafish Sost is involved in the same developmental processes as Lrp5. The observed defects in 
the same cellular aspects of CNCC development suggest that Lrp5/Sost interaction might enable 
some kind of fine-tuning of canonical Wnt signal transduction to tightly control the level of 
activation of downstream targets implicated in cell cycle progression and migratory behavior of 
CNCCs. An alteration of this balanced activity in any direction might lead to similar defects as 
observed in the lrp5 and sost morphants. 
The morphogenetic fates of individual streams of migratory CNCCs have been described earlier 
(reviewed by Kimmel et al., 2001). I employed the fli1:EGFP transgenic line to follow the fate of 
postmigratory cells to their morphogenetic destinations in the craniofacial skeleton and to 
compare this process in the morphant situation. In contrast to the sox10:GFP line, where GFP 
expression is limited to NCCs, the fli1 line shows EGFP reporter expression not only in NCCs but 
in the entire pharyngeal arches. Thus, this line gives more information about the overall 
morphology of these developing structures. I could confirm the previous findings and also show 
how the lack of branchial CNCCs results in failure of ceratobranchial morphogenesis. Also, 
morphogenesis of the 5th ceratobranchials could be followed and seemed less affected than the 
other four in the lrp5 morphant situation. This confirmed the observations made by skeletal 
staining at 7dpf.    
lrp5 and sost are expressed in and around derivatives of CNCCs throughout development, which 
suggests additional functions throughout morphogenesis. However, since the described defects 
occured already at relatively early stages we can only speculate about extended functions in the 
progressing craniofacial morphogenesis as well as later bone homeostasis.   
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4.4. A teleost specific function for Lrp5 in craniofacial development? 
Previously, the functions described for Lrp5 and Sost were limited to bone metabolism (Gong et 
al., 2001; Balemans et al., 2001) with an additional role for Lrp5 in eye vascularization. Loss-of-
function mutations in Lrp5 manifested as osteoporosis pseudoglioma (OPPG) syndrome. The 
same defects were also found in Lrp5 loss-of-function mutant mice (Kato et al., 2002). 
Interestingly however, no craniofacial deficiencies or any other forms of neural crest related 
abnormalities have been reported. However, observations in human patients suffering from 
genetically inherited LRP5 gain-of-function mutations reported mild aberrations in the skull 
anatomy. From early age onwards, some of these patients are characterized by abnormally 
thickened jaws or lobulated palates (Boyden et al., 2002). Young patients with a specific gain-of-
function mutation (A214T) also suffered from craniosynostosis (Kwee et al. 2005). The early 
onset of these deformations suggests that they are not a result of a progressive sclerosteosis as 
described in all other Lrp5 gain-of-function mutants. Furthermore, it is well established that the 
jaw, palate and skull are derivatives of the human neural crest. Thus, one could speculate that the 
observations made in the human patients are a result of neural crest aberrations that occurred 
during embryonic development. An additional defect in humans carrying LRP5 loss-of-function 
mutations was shown in the eye vasculature. It was reported in mice that during embryonic 
development the transient hyaloid blood vessels fail to undergo macrophage induced apoptosis 
(Kato et al., 2002). Interestingly, it could be shown through fate mapping studies that also the 
hyaloid blood vessels partially originate from CNCCs (Gage et al., 2005). Thus, it could be 
possible that the eye vasculature defect observed in humans and mice is a result of losing a 
putative early Lrp5 function in CNCC developmental in mammals. In the zebrafish lrp5 knock-
down situation, I observed reduced eye size. However, this organ has not been in the focus of my 
experiments and could be subject to additional experiments in the future.  
The manifestation of Sost loss-of-function mutations, on the other hand, was described as so 
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called van Buchem disease (Balemans et al., 2002) and sclerosteosis (Balemans et al., 2001), both 
characterized by progressively sclerosing limbs and skull. Although developmental defects are 
evident as syndactyly in sclerosteosis patients they cannot be directly linked to impaired CNCC 
development.   
4.5. An evolutionary comparison of Lrp5 function 
Notably, our observations indicate a more important role for Lrp5 during craniofacial 
morphogenesis in zebrafish than compared to the situation in mammals. Loss-of-function in fish 
leads to more severe craniofacial defects compared to the defects described for human gain-of-
function mutations. I therefore speculate that in non-mammalian vertebrate species Lrp5 might 
play a more crucial role in this process compared to mammals. My experiments also indicate that 
the most affected structures in the craniofacial skeleton are the ceratobranchials that build up the 
gills. These structures derive from the branchial streams of CNCCs that have shifted their 
morphogenetic destination in the course of vertebrate evolution. In amphibians, they generate 
cells that eventually build up the bones of the skull proper (Olsson & Hanken 1996). However, in 
human embryonic development branchial NCCs play a minor role as they build up craniofacial 
elements such as the squamosal, alisphenoid or the hyoid bone (reviewed by Santagati and Rijli, 
2003). None of these elements have been shown to be affected in Lrp5 gain of function mutants.  
Nonetheless, it is tempting to speculate that the evolutionary shift of branchial migratory NCC 
morphogenetic destinations came together with a restructuring of Lrp5 function from a role in 
overall craniofacial development to a merely rudimental role.  
Due to experimental limitations of our Mo mediated knock-down approach we could not make 
any conclusion about a possible role of zebrafish Lrp5/Sost in juvenile or adult bone mass 
regulation. Since Mos only exert their function during embryonic and early larval development in 
addition to the early death of morphant larvae due to lack of gills, other experimental strategies, 
such as mutant analysis or zinc finger nuclease approaches, will have to be employed to address 
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these questions.  
Knock-down of lrp5/sost in zebrafish does not only affect the craniofacial skeleton. The hindbrain 
also seems to be strongly affected as its ventricle appears widely inflated. This is in line with the 
lrp5/sost expression pattern. We therefore suspect that Lrp5 and Sot might also have additional 
roles in neurogenesis, which was not subject of experiments in the presented study and will have 
to be assessed in the future.  
 
Appendix 
Table 2. Statistics of lrp5Mo injections. For definition of classI and classII defects see page 65 
and Fig. 16H,I. 
 
Table 3. Statistics of sostMo injections. For definition of classI and classII defects see page 65 






Fig. 24. Mismatch morphant control experiments. (A,B) Wild-type embryo stained for dlx2a. 
(C,D) Wild-type embryo stained for crestin. (E,F) lrp5 mismatch  morphant stained for dlx2a. 
(G,H) lrp5 mismatch  morphant embryo stained for crestin. (I,J) sost mismatch  morphant stained 
for dlx2a. (K,L) sost mismatch  morphant embryo stained for crestin. Note that mismatch Mo 
injection does not result in alterations of dlx2a/crestin expression patterns. Anterior is to the left 
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